<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>healthcare Archives - Filter</title>
	<atom:link href="/tag/healthcare/feed/index.xml" rel="self" type="application/rss+xml" />
	<link>/tag/healthcare/</link>
	<description>Harm reduction journalism</description>
	<lastBuildDate>Fri, 30 Sep 2022 16:34:50 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.9</generator>
	<item>
		<title>Australia&#8217;s Experiment With Prescription-Only Vapes Has Failed</title>
		<link>/australia-vape-prescriptions/</link>
		
		<dc:creator><![CDATA[Colin Mendelsohn]]></dc:creator>
		<pubDate>Fri, 30 Sep 2022 10:16:57 +0000</pubDate>
				<category><![CDATA[FilterMag]]></category>
		<category><![CDATA[Politics + Legalization]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[international]]></category>
		<category><![CDATA[nicotine]]></category>
		<category><![CDATA[vaping]]></category>
		<guid isPermaLink="false">/?p=15106</guid>

					<description><![CDATA[<p>The Australian government’s medical, prescription-only model for nicotine vaping was introduced on October 1, 2021, and has been a resounding ...</p>
<p>The post <a href="/australia-vape-prescriptions/">Australia&#8217;s Experiment With Prescription-Only Vapes Has Failed</a> appeared first on <a href="/">Filter</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span class="wpsdc-drop-cap">T</span>he Australian government’s medical, prescription-only model for nicotine vaping <a href="https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/preventing-nicotine-uptake-by-youngaustralians-" target="_blank" rel="noopener noreferrer">was introduced</a> on October 1, 2021, and has been a resounding policy failure. Like most prohibitionist policies, it has created a thriving illicit market and detrimental public health outcomes.</p>
<p>To legally possess <a href="/buying-nicotine-in-australia-is-about-to-get-even-harder/" target="_blank" rel="noopener noreferrer">nicotine e-liquid</a> to quit smoking, vapers <a href="/australia-restrictions-vaping-nicotine/" target="_blank" rel="noopener noreferrer">must get a doctor’s prescription</a> and purchase supplies from pharmacies or international online vendors. The sale of nicotine from vape shops and other retail outlets is banned.</p>
<blockquote><p>Predictably, this prohibitionist model has created a thriving illicit market.</p></blockquote>
<p>The regulations were <a href="https://www.tga.gov.au/products/medicines/prescription-medicines/nicotine-vaping-products-hub/nicotine-vaping-product-access" target="_blank" rel="noopener noreferrer">intended</a> to prevent youth vaping and to allow access for adults as a smoking cessation aid. After 12 months, it is clear that they have achieved neither of those goals. In fact, they have had the opposite effect, as my new report <a href="https://colinmendelsohn.com.au/wp-content/uploads/2022/09/12-month-review-of-Australias-vaping-regulations-1Oct2022-1.pdf" target="_blank" rel="noopener noreferrer">indicates</a>.</p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Illicit Market, Raids and Increased Youth Vaping</h4>
<p>Predictably, this prohibitionist model <a href="https://westernweekender.com.au/2022/09/calls-for-better-regulation-of-vapes-as-black-market-booms/" target="_blank" rel="noopener noreferrer">has created</a> a thriving illicit market for unregulated vaping products that <a href="https://www.legislation.gov.au/Details/F2021L00595" target="_blank" rel="noopener noreferrer">do not comply with Australian standards</a>. Massive numbers of <a href="https://www.vice.com/en/article/n7zb37/we-got-your-vapes-tested-in-a-lab-heres-what-we-found?" target="_blank" rel="noopener noreferrer">poor-quality</a> devices are being <a href="https://www.dailymail.co.uk/news/article-10228299/Smoke-store-Darlinghurst-Sydney-fined-vapes.html" target="_blank" rel="noopener noreferrer">imported</a> from China and are widely sold by tobacconists, convenience stores, online and on social media. Criminal organizations <a href="https://tasmaniantimes.com/2022/02/illegal-tobacco-and-cigarette-imports-surge/" target="_blank" rel="noopener noreferrer">are becoming</a> increasingly involved.</p>
<p>Enforcement of the illicit market is minimal, but some businesses are raided. When that happens, many just <a href="https://www.couriermail.com.au/subscribe/news/1/?sourceCode=CMWEB_WRE170_a_GGL&dest=https%3A%2F%2Fwww.couriermail.com.au%2Fnews%2Fqueensland%2Fbundaberg%2Fqld-health-urges-wide-bay-residents-to-report-illegal-tobacco%2Fnews-story%2Fcb8a21c6ccf8c61ec8f9e9ce300da07e&memtype=anonymous&mode=premium&v21=dynamic-groupa-test-noscore&V21spcbehaviour=append">resume</a> selling illegal products within weeks. The vast majority of illegal imports are not detected.</p>
<p>The widespread availability of disposable nicotine vapes on the illicit market has left consumers less protected and devastated the legal retail vape industry—which continues to sell hardware and nicotine-free liquids, but is not allowed to sell nicotine. Many shops have reported a substantial <a href="https://westernweekender.com.au/2022/09/calls-for-better-regulation-of-vapes-as-black-market-booms/" target="_blank" rel="noopener noreferrer">decline in sales</a> and some have <a href="https://www.news.com.au/lifestyle/health/kids-tapping-into-vape-black-market/news-story/6c85e2ba2d5dd40040c1a6a66d42da8c" target="_blank" rel="noopener noreferrer">closed</a> as a result. As many vapers are now buying illegal nicotine disposables, these retail products are now being used far less. (Previously vapers bought their nicotine-free liquid locally and added nicotine from overseas, or just bought hardware locally and premixed nicotine juice from overseas. Now many do neither.)</p>
<blockquote><p>Schools are responding by installing vape detectors and confiscating vapes.</p></blockquote>
<p>Vaping by adolescents has reportedly increased in Australia since the new regulations began. There are almost daily <a href="https://www.news.com.au/lifestyle/parenting/school-life/alarming-new-report-on-aussie-teens-using-ecigarettes/news-story/71080d743dc35286c0792808278e95a8" target="_blank" rel="noopener noreferrer">media reports</a> of widespread youth vaping. High-nicotine (5 to 6 percent) disposable vapes are freely sold on the illicit market. With no age controls in an unregulated market, they are easily accessible by teens from tobacconists, convenience stores, gas stations and even in <a href="https://www.dailymail.co.uk/news/article-10466789/Vape-Australia-Uber-drivers-making-fortune-deliveringelectronic-" target="_blank" rel="noopener noreferrer">Ubers</a>. Devices are easily purchased on social media, <a href="https://www.abc.net.au/news/2022-06-27/inside-the-thriving-black-market-for-nicotine-vapes/101176544" target="_blank" rel="noopener noreferrer">often with a home delivery service</a>.</p>
<p>There <a href="https://www.perthnow.com.au/news/health/vaping-on-the-rise-in-primary-schools-survey-of-primary-school-teachers-reveals--c-7581587" target="_blank" rel="noopener noreferrer">are also increasing reports</a> from schools of teens vaping in bathrooms and the classroom. Some schools are responding by installing <a href="https://www.dailymail.co.uk/news/article-10933053/Aussie-schools-install-vape-detectors-inside-bathrooms-alert-teachers-children-vaping.html" target="_blank" rel="noopener noreferrer">vape detectors</a> in the toilets, <a href="https://au.news.yahoo.com/mum-furious-sa-high-school-removes-bathroom-doors-053203193.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAEGVP3I1oXNDsMuS658g5PbtOer6WZB2mhqykNtM7MV_Mp8I2GvMDxEoUYWMPpiCkaGk4VYTFp7eCKFrriNssVBAPfn2kr8nNoc8xXvqZ-vEnynVAyD2ebEjrRIBi5iImFF1yG_XED3cHPs_GD4Sh5qg4BhNiNfpkTsp9icIP0Q5" target="_blank" rel="noopener noreferrer">removing</a> toilet doors, <a href="https://www.smh.com.au/national/nsw/schools-lock-toilets-to-tackle-rampant-vaping-20220225-p59zqt.html" target="_blank" rel="noopener noreferrer">locking</a> toilets during class hours, installing <a href="https://www.dailytelegraph.com.au/subscribe/news/1/?sourceCode=DTWEB_WRE170_a_GGL&dest=https%3A%2F%2Fwww.dailytelegraph.com.au%2Feducation-new-south-wales%2Fparents-at-kambala-school-in-rose-bay-concerned-about-surveillance-cameras-in-change-rooms%2Fnews-story%2F428f0a1f1e74c4025c357942a72c63b0&memtype=anonymous&mode=premium&v21=dynamic-low-control-score&V21spcbehaviour=append" target="_blank" rel="noopener noreferrer">security cameras</a>, <a href="https://thewest.com.au/stories/hale-suspends-14-students-for-vaping-on-school-grounds/" target="_blank" rel="noopener noreferrer">suspending</a> students for vaping at school and <a href="https://www.dailymail.co.uk/news/article-10956791/Australian-vaping-crisis-Teen-opens-addiction-amid-claims-vaping-harmful-smoking.html">confiscating</a> vapes.</p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Reduced Access for Adults</h4>
<p>The prescription model has made it harder for adults who smoke to legally access nicotine vapes to quit smoking. Legal access is complex, onerous and costly. Perversely, it is far easier to buy deadly cigarettes.</p>
<p>According to two <a href="https://aacs.org.au/1-1-million-reasons-to-regulate-australias-illegal-vape-industry/" target="_blank" rel="noopener noreferrer">recent</a> <a href="https://aacs.org.au/1-1-million-reasons-to-regulate-australias-illegal-vape-industry/" target="_blank" rel="noopener noreferrer">surveys</a>, between 88 to 97 percent of vapers do not have a prescription and only <a href="https://aacs.org.au/wp-content/uploads/2022/08/AACS-CMA-Research-Attachment.pdf">2 percent of purchases</a> are made from a pharmacy, the government’s preferred model. However, it is a <a href="https://www.criminaldefencelawyers.com.au/blog/is-vaping-illegal-in-australia/?" target="_blank" rel="noopener noreferrer">criminal offense</a> to possess nicotine without a prescription, punishable by fines up to $45,000 and potential jail terms.</p>
<blockquote><p>Only 200 out of 31,000 general practitioners were publicly listed as nicotine prescribers.</p></blockquote>
<p>Doctors have not supported the regulations. In June 2022, only 200 out of 31,000 general practitioners (GPs) <a href="https://www.tga.gov.au/resources/resource/guidance/authorised-prescribers-unapproved-nicotine-vaping-products" target="_blank" rel="noopener noreferrer">were publicly listed as nicotine prescribers</a>. GPs cannot advertise their availability for nicotine prescribing, so it very difficult for vapers to find a prescriber.</p>
<p>GPs are skeptical about vaping and are reluctant to prescribe nicotine. They are constantly exposed to negative messaging by the Therapeutic Goods Administration (Australia’s medicines regulator), government agencies, medical associations and colleges, health charities and the mainstream media. GPs also fear medico-legal repercussions for prescribing unapproved products, and no vaping products are approved by the medicines regulator. GPs know very little about vaping, and most do not know how to write a nicotine prescription.</p>
<p>Only a handful of community and online pharmacies dispense nicotine liquid. Those that do stock nicotine products have a very small range to choose from.</p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Admit the Mistake</h4>
<p>The only way forward is to replace the prescription-only model and the illicit market it fosters with a legal and regulated retail market. Nicotine liquid should be an adult consumer product, sold from licensed retail outlets such as vape shops, convenience stores, tobacconists and general stores as it is in other countries. There should be strict age verification and penalties up to loss of license for underage sales.</p>
<p>It would be worthwhile having a dual pathway, however with both consumer<em> and</em> <a href="/nhs-prescribing-vapes/">medically approved</a> products which doctors can prescribe. This would legitimize vaping for doctors and reassure them and the public about safety concerns.</p>
<p>Australia’s misguided experiment has failed. We need to admit the mistake and adopt a more realistic regulatory model to support Australians who smoke and vape.</p>
<p>&nbsp;</p>
<hr />
<p>&nbsp;</p>
<p><em>Photograph via <a href="https://colinmendelsohn.com.au/nicotine-prescriptions/">ColinMendelsohn.com.au</a></em></p>
<p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=%2Faustralia-vape-prescriptions%2F&linkname=Australia%E2%80%99s%20Experiment%20With%20Prescription-Only%20Vapes%20Has%20Failed" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=%2Faustralia-vape-prescriptions%2F&linkname=Australia%E2%80%99s%20Experiment%20With%20Prescription-Only%20Vapes%20Has%20Failed" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_email" href="https://www.addtoany.com/add_to/email?linkurl=%2Faustralia-vape-prescriptions%2F&linkname=Australia%E2%80%99s%20Experiment%20With%20Prescription-Only%20Vapes%20Has%20Failed" title="Email" rel="nofollow noopener" target="_blank"></a></p><p>The post <a href="/australia-vape-prescriptions/">Australia&#8217;s Experiment With Prescription-Only Vapes Has Failed</a> appeared first on <a href="/">Filter</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Methadone Clinics Step Up Their Backlash Against Reform</title>
		<link>/methadone-clinic-reform-backlash/</link>
		
		<dc:creator><![CDATA[Helen Redmond]]></dc:creator>
		<pubDate>Tue, 02 Aug 2022 15:44:18 +0000</pubDate>
				<category><![CDATA[FilterMag]]></category>
		<category><![CDATA[Use + Harm Reduction]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[MAT]]></category>
		<category><![CDATA[methadone]]></category>
		<guid isPermaLink="false">/?p=14794</guid>

					<description><![CDATA[<p>The members of the American Association for the Treatment of Opioid Dependence (AATOD) are outraged. This national organization represents the ...</p>
<p>The post <a href="/methadone-clinic-reform-backlash/">Methadone Clinics Step Up Their Backlash Against Reform</a> appeared first on <a href="/">Filter</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span class="wpsdc-drop-cap">T</span>he members of the American Association for the Treatment of Opioid Dependence (AATOD) are outraged. This national organization <span style="font-weight: 400;">represents the interests of over</span><a href="http://www.aatod.org/wp-content/uploads/2022/03/Regulatory-Reform-and-Policy-Initiatives-for-OTPs-in-a-Post-COVID-19-World-09302021.pdf"> <span style="font-weight: 400;">1,200 opioid treatment programs</span></a> <span style="font-weight: 400;">(OTPs), also known as methadone clinics. The group’s anger was triggered by two bills: the Opioid Treatment Access Act (OTAA), which the group labels as “dangerous,” and the Mainstreaming Addiction Treatment (MAT) Act. Each bill recommends a few modest changes to loosen restrictions on access to methadone and buprenorphine.</span></p>
<p><span style="font-weight: 400;">To kill the bills, the group created fact sheets that are full of misleading statements, exaggerations and lies of omission, as well as being condescending to people who take methadone.</span></p>
<p><span style="font-weight: 400;">According to Mark Parrino, founder and </span><a href="http://www.aatod.org/about-us/our-board-of-directors/"><span style="font-weight: 400;">president</span></a><span style="font-weight: 400;"> of AATOD and a former </span><a href="https://atforum.com/2022/07/methadone-reform-ny-part-2/"><span style="font-weight: 400;">clinic owner</span></a><span style="font-weight: 400;">, the group began circulating these documents three months ago, giving them to state member chapters and “a number of congressional staff members.” He told </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">, “They were written through our legislative committee membership as a way of expressing our concern about two pieces of legislation.”</span></p>
<blockquote><p><span style="font-weight: 400;">Members sense a direct threat to their power and profits.</span></p></blockquote>
<p><span style="font-weight: 400;">The misinformation in the documents is shocking from an organization that purports to believe in</span><a href="http://www.aatod.org/about-us/our-activities/"> <span style="font-weight: 400;">“evidence-based clinical practice.”</span></a><span style="font-weight: 400;"> AATOD went ballistic over a provision in the OTAA that allows a small group of board certified physicians </span><i><span style="font-weight: 400;">outside</span></i><span style="font-weight: 400;"> of OTPs to prescribe methadone, with pharmacy pick-up. Members sense a direct threat to their power and profits. Clinic owners prefer the status quo that has given them cartel-like control over methadone for over 40 years.</span></p>
<p><span style="font-weight: 400;">The OTAA fact sheet goes off the rails by insinuating that relaxing rigid clinic regulations and licensing outside doctors to prescribe methadone would exacerbate the overdose crisis: “It will result in physicians prescribing a powerful medication with no effort to limit diversion, no counseling, no drug testing … exactly how we got into the current opioid epidemic and record numbers of deaths.”</span></p>
<p><span style="font-weight: 400;">In fact, it’s the opposite. The OTP system is partly to blame for the massive increase in overdose deaths, because it’s still easier to get fentanyl on the street than it is to get into and stay in a methadone program. Methadone is proven to </span><a href="https://nap.nationalacademies.org/resource/25310/032019_OUDhighlights.pdf"><span style="font-weight: 400;">cut</span></a><span style="font-weight: 400;"> the death rate for people with opioid use disorder (OUD) by </span><a href="https://www.bmj.com/content/357/bmj.j1550"><span style="font-weight: 400;">50 percent or more</span></a><span style="font-weight: 400;">, but not if you can&#8217;t get it.</span></p>
<p><span style="font-weight: 400;">Like the DEA itself, AATOD </span><i><span style="font-weight: 400;">always </span></i><span style="font-weight: 400;">invokes “diversion”—the notion of people giving or selling their medications to others—to block reform.</span></p>
<p><span style="font-weight: 400;">“Spotlighting diversion when we know that methadone (diverted or otherwise) is the best tool to stem the worst overdose crisis in American history is the wrong move,” Aaron Ferguson, a methadone liaison with the Urban Survivors Union, told </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">. “Prescribing all medications comes with a cost/benefit analysis of treatment compared to none at all, and methadone and people who use drugs are no exception to this general rule of health care.”</span></p>
<p><span style="font-weight: 400;">ATTOD’s insistence that counseling is necessary for methadone patients is also false. A National Academy of Sciences, Engineering, and Medicine Consensus report</span><a href="https://nap.nationalacademies.org/catalog/25310/medications-for-opioid-use-disorder-save-lives"> <span style="font-weight: 400;">concluded in 2019</span></a> <span style="font-weight: 400;">that methadone treatment should not be contingent on the availability of other services. The real reason for AATOD’s position? Counseling is a billable service.</span></p>
<blockquote><p><span style="font-weight: 400;">&#8220;I need methadone to live a normal life but I feel doomed every day.”</span></p></blockquote>
<p><span style="font-weight: 400;">“I am still frustrated to have to</span><a href="/methadone-patient-covid-rules/"> <span style="font-weight: 400;">participate in coerced talk therapy</span></a> <span style="font-weight: 400;">with a rotating cast of counselors to get my medication,” one methadone user told </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">. Another person shared her exasperation with me privately: “What really blows my mind is that people can go buy guns, guns that can kill people and just have them forever. No daily, weekly, monthly, yearly check-in. No drug tests, no fucking mandatory counseling sessions with a new college graduate every other month. I need methadone to live a normal life but I feel doomed every day.”</span></p>
<p><span style="font-weight: 400;">Mandatory counseling is an oxymoron, and is unethical because of the huge power imbalance between patient and counselor. For example, if a person reveals use of an illicit drug or a urine screen is positive, their counselor has the authority to revoke take-home bottles, </span><a href="https://www.liquidhandcuffsdoc.com/"><span style="font-weight: 400;">cancel a vacation</span></a><span style="font-weight: 400;"> or subject them to “administrative discharge”—i.e. kick them out of the clinic. Missing a counseling session can also result in sanctions. It is outrageous and unacceptable that counselors have this power over patients&#8217; lives. No true therapeutic alliance can be built in these excessively punitive and coercive circumstances.</span></p>
<p><span style="font-weight: 400;">AATOD refuses to acknowledge that clinic-generated barriers to care are killing people. OTPs’ culture of cruelty, as described in the</span><a href="https://sway.office.com/UjvQx4ZNnXAYxhe7?ref=Link&mc_cid=9754583648&mc_eid=51fa67f051"> <i><span style="font-weight: 400;">Methadone Manifesto</span></i></a><span style="font-weight: 400;">, sees their punitive policies literally drive people out of treatment, putting them at great risk of fentanyl-involved overdose. Almost</span><a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0232086"> <span style="font-weight: 400;">half of people</span></a><span style="font-weight: 400;"> with OUD are not retained in treatment at 12 months, and this rate reduces further over time.</span></p>
<p><span style="font-weight: 400;">AATOD’s fact sheet also attacks pharmacy-based dispensing, like that seen in the UK and Canada. It warns: “Suggesting that methadone is safe and effective for OUD in any other setting [other than an OTP] is scientific appropriation: it is not evidence-based.”</span></p>
<p><span style="font-weight: 400;">This is another misleading statement. The efficacy of pharmacy-based methadone prescribing </span><i><span style="font-weight: 400;">is</span></i><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544670/"> <span style="font-weight: 400;">evidence-based</span></a><span style="font-weight: 400;">. This low-threshold model has been in existence for over 40 years. It doesn’t create obstacles to getting medication or trigger NIMBY protests. It has excellent retention rates, and mitigates stigma.</span></p>
<p><span style="font-weight: 400;">The fact sheet wrongly asserts that pharmacists in Scotland and England don’t supervise methadone consumption. They do. To be sure, no system is perfect, but picking up a prescription of methadone at a local pharmacy makes a lot more sense than the current, outdated OTP model, especially during an ongoing overdose crisis and a pandemic.</span></p>
<blockquote><p><span style="font-weight: 400;">“To circulate a document so out of step with the medical and scientific consensus raises questions about AATOD’s motivations and leadership.”</span></p></blockquote>
<p><span style="font-weight: 400;">People who take methadone have been</span><a href="https://issuu.com/harmreduction/docs/hrc_2001_spring"> <span style="font-weight: 400;">screaming this into the void for decades</span></a>,<span style="font-weight: 400;"> but ATTOD hasn’t been listening. A recent study conducted in the US demonstrated the desire for liberation from the clinic system. Study participants who received methadone at a pharmacy reported high rates of satisfaction and</span><a href="https://onlinelibrary.wiley.com/doi/10.1111/add.15641"> <span style="font-weight: 400;">endorsed</span></a><span style="font-weight: 400;"> the statement, “Pharmacy is the right location for receiving methadone for MMT.”</span></p>
<p><span style="font-weight: 400;">“To circulate a document so out of step with the medical and scientific consensus raises questions about AATOD’s motivations and leadership,” Dr. Paul Joudrey, an assistant professor at the University of Pittsburgh School of Medicine told </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">. “They cannot cherry pick the science just because they don&#8217;t want things to change. They should listen to expert groups like the National Academy of Science and Medicine and put patients&#8217; needs first.” Joudrey has written a point-by-point refutation of the AATOD fact sheets.</span></p>
<p><span style="font-weight: 400;">Parrino pushed back on some of the criticism of the fact sheets. He told </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;"> he opposes prescribing methadone for OUD outside clinics because, “It’s important to underscore the fact that methadone maintenance treatment as used in an OTP… uses a team approach, not a singular practitioner approach in dealing with opioid use.” A safety concern he raised with office-based prescribing was use of </span><a href="/how-helpful-or-harmful-are-prescription-drug-monitoring-programs/"><span style="font-weight: 400;">prescription drug monitoring programs</span></a><span style="font-weight: 400;">. “A majority of practitioners do not check the PDMP when other practitioners are prescribing opioids including methadone for pain management.”</span></p>
<p><span style="font-weight: 400;">As for therapy, he argued, “The claim is that counseling really doesn’t do much to enhance the use of the medication. This conclusion was based on limited studies with a small patient population. It is also an attempt to marginalize more than 60 years of evidence-based research that demonstrates patient outcomes do improve.” Parrino cited a </span><a href="https://www.jstor.org/stable/2137033"><span style="font-weight: 400;">dated study published in 1988</span></a><span style="font-weight: 400;"> to make this point.</span></p>
<p><span style="font-weight: 400;">AATOD’s attack is a response to unprecedented changes to methadone regulations that occurred during the pandemic. COVID-19 cracked open the clinic system in a way nothing else has. This revealed a number of facts that are inconvenient for AATOD—and which are nowhere to be found in its fact sheets.</span></p>
<p><span style="font-weight: 400;">The Substance Abuse and Mental Health Services Administration (SAMHSA)</span><a href="https://www.samhsa.gov/sites/default/files/otp-guidance-20200316.pdf"> <span style="font-weight: 400;">emergency guidelines</span></a><span style="font-weight: 400;"> permitted clinics to give more take-home bottles of methadone; normally it takes months or even years to “earn” an increase. To reduce the spread of the coronavirus, weekly drug screening was</span><a href="https://www.journalofsubstanceabusetreatment.com/article/S0740-5472(20)30476-1/fulltext"> <span style="font-weight: 400;">eliminated</span></a><span style="font-weight: 400;"> in some clinics, as was mandatory group counseling. Thousands of patients were freed from</span><a href="https://www.sciencedirect.com/science/article/pii/S0740547220305031#bbb0030"> <span style="font-weight: 400;">rushing to a clinic six days a week</span></a><span style="font-weight: 400;">, from urine testing and from counseling sessions that are often a waste of time.</span></p>
<p><span style="font-weight: 400;">So what happened? The sky didn’t fall, nor did</span><a href="https://atforum.com/2020/07/extended-methadone-take-homes-during-covid-nothing-but-success/"> <span style="font-weight: 400;">diversion or overdose rates increase</span></a><span style="font-weight: 400;">.</span><a href="https://www.sciencedirect.com/science/article/pii/S0740547221000027"> <span style="font-weight: 400;">Numerous studies</span></a><span style="font-weight: 400;"> conducted during the pandemic back this up: There were very few</span><a href="https://www.samhsa.gov/newsroom/press-announcements/202111181000"> <span style="font-weight: 400;">incidents of diversion</span></a><span style="font-weight: 400;"> and allowing more take-home bottles</span><a href="https://www.sciencedirect.com/science/article/abs/pii/S0740547221001756"> <span style="font-weight: 400;">didn’t increase overdose</span></a> <span style="font-weight: 400;">deaths. One</span><a href="https://pubmed.ncbi.nlm.nih.gov/34670453/"> <span style="font-weight: 400;">study concluded</span></a><span style="font-weight: 400;">, “Despite a near-doubling of take-home methadone doses during the COVID-19 exemption period, the increase in take-home doses was not associated with negative treatment outcomes in methadone-adherent clients.”</span></p>
<p><span style="font-weight: 400;">Another</span><a href="https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2793744?utm_source=twitter&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=071522#.YtHShxxzyO4.twitter"> <span style="font-weight: 400;">study</span></a><span style="font-weight: 400;">, just published by researchers at the National Institute on Drug Abuse (NIDA), also found that OTP take-home policy changes didn’t increase overdose deaths and stated, “Coupled with research demonstrating improved patient satisfaction, treatment access, and engagement from these policies these findings can inform decisions about permanently expanding take-home methadone.”</span></p>
<blockquote><p><span style="font-weight: 400;">This new research is good news for people who take methadone but bad news for AATOD, because these studies conclusively debunk its bogus claims.</span></p></blockquote>
<p><span style="font-weight: 400;">“There’s a group of people that just don’t want to go to a methadone clinic … How do we address this?” </span><a href="https://www.latimes.com/california/story/2022-05-11/la-skid-row-overdose-epicenter-methadone-access"><span style="font-weight: 400;">asked</span> </a><span style="font-weight: 400;">NIDA Director Dr. Nora Volkow recently. Some of the answers were staring her in the face.</span></p>
<p><span style="font-weight: 400;">Parrino’s response to the new research was tepid: “It’s true that the COVID-19 pandemic gave OTPs the opportunity to provide greater amounts of take-home medication. Much has been made about the fact that there were not resulting overdoses and methadone diversion. That is true to a point. The more hidden story is that the OTPs were always monitoring how the patient was using take-home medication, even during the early period of March 2020 to September 2020 when toxicology reports were not being collected to further protect the patients and staff.”</span></p>
<p><span style="font-weight: 400;">All of this new research is good news for people who take methadone but bad news for AATOD, because these studies conclusively debunk its bogus claims. OTPs are freaking out because for the first time their fucked up, carceral system is under a microscope. They’re apoplectic that groups of methadone users, health care providers, researchers, politicians and policymakers are coming together to challenge their hegemony.</span></p>
<p><span style="font-weight: 400;">“What is certain is that the increasing overdose rates is unacceptable, and our system does need to improve in terms of its integration and in terms of its overall guidance in treating this disorder,” Parrino said</span><i><span style="font-weight: 400;">.</span></i></p>
<blockquote><p><span style="font-weight: 400;">The profit motive</span> <span style="font-weight: 400;">permeates the OTP-industrial complex.</span></p></blockquote>
<p><span style="font-weight: 400;">So why is AATOD trying to defeat legislation that will save lives? </span><span style="font-weight: 400;">AATOD is doubling down and balling up its fists to fend off any reform that doesn’t center the clinic system. The profit motive</span> <span style="font-weight: 400;">permeates the OTP-industrial complex—from drug testing to video surveillance systems to counseling to attendance requirements. Follow the money. They </span><i><span style="font-weight: 400;">want </span></i><span style="font-weight: 400;">patients to come to the clinics six days a week and </span><i><span style="font-weight: 400;">not </span></i><span style="font-weight: 400;">get 14 or 28 day take-homes, because in order to make bank they need to bill insurance or patients for </span><i><span style="font-weight: 400;">every single visit</span></i><span style="font-weight: 400;">. More take-home bottles mean less cash flow. Investors in for-profit clinics—</span><a href="https://baymark.com/"><span style="font-weight: 400;">BayMark Health Services</span></a><span style="font-weight: 400;"> has estimated annual revenue of </span><a href="https://growjo.com/company/BayMark_Health_Services"><span style="font-weight: 400;">$86.7 million</span></a><span style="font-weight: 400;">—don’t like that!</span></p>
<p><span style="font-weight: 400;">The clinic wardens of AATOD love the carceral structure of OTPs that keep patients vulnerable and subordinate, because it ensures that few can “earn” their way out. </span><i><span style="font-weight: 400;">Cha-ching</span></i><span style="font-weight: 400;">! The prospect of doctors prescribing methadone in primary care or other non-OTP settings is a mortal threat to AATOD’s existence and they will attempt to prevent it by any means necessary, including lying and scaremongering.</span></p>
<p><span style="font-weight: 400;">AATOD’s “factless” fact sheets are just an opening salvo. The organization is well-funded, has decades of lobbying and legislative experience at the state and federal levels, and deep connections to the DEA and SAMHSA. They will not take off the “liquid handcuffs” and let the prisoners go without a fight.   </span></p>
<p>&nbsp;</p>
<hr />
<p>&nbsp;</p>
<p><em>Photograph of a sign at a methadone clinic, reading &#8220;Groups are not optional &#8230; Non-compliance or no show to group will result in take-home [suspension],&#8221; by Helen Redmond</em></p>
<p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=%2Fmethadone-clinic-reform-backlash%2F&linkname=Methadone%20Clinics%20Step%20Up%20Their%20Backlash%20Against%20Reform" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=%2Fmethadone-clinic-reform-backlash%2F&linkname=Methadone%20Clinics%20Step%20Up%20Their%20Backlash%20Against%20Reform" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_email" href="https://www.addtoany.com/add_to/email?linkurl=%2Fmethadone-clinic-reform-backlash%2F&linkname=Methadone%20Clinics%20Step%20Up%20Their%20Backlash%20Against%20Reform" title="Email" rel="nofollow noopener" target="_blank"></a></p><p>The post <a href="/methadone-clinic-reform-backlash/">Methadone Clinics Step Up Their Backlash Against Reform</a> appeared first on <a href="/">Filter</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>How Fear, Misinformation, Stigma Have Devastated US Pain Patients</title>
		<link>/pain-patients-opioids-fear/</link>
		
		<dc:creator><![CDATA[Sessi Kuwabara Blanchard]]></dc:creator>
		<pubDate>Wed, 28 Apr 2021 11:46:41 +0000</pubDate>
				<category><![CDATA[FilterMag]]></category>
		<category><![CDATA[Intersections + Injustice]]></category>
		<category><![CDATA[criminal injustice]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[opioids]]></category>
		<category><![CDATA[pain]]></category>
		<guid isPermaLink="false">/?p=11992</guid>

					<description><![CDATA[<p>Tamera Lynn Stewart had been taking prescribed opioids for 12 years to treat her chronic pain, following some cancer-related surgeries. ...</p>
<p>The post <a href="/pain-patients-opioids-fear/">How Fear, Misinformation, Stigma Have Devastated US Pain Patients</a> appeared first on <a href="/">Filter</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span class="wpsdc-drop-cap">T</span>amera Lynn Stewart had been taking prescribed opioids for 12 years to treat her chronic pain, following some cancer-related surgeries. Then one day in April 2018, her doctor told her he could no longer maintain the treatment that had worked so well for all those years.</p>
<p><i><span style="font-weight: 400;">I’m so sorry to tell you, but the state law is changing, and your dose was seven times higher than the dose Oklohoma law is going to [permit], </span></i><span style="font-weight: 400;">Stewart recalled him saying</span><i><span style="font-weight: 400;">. I have to have your doses reduced by November</span></i><span style="font-weight: 400;">.</span></p>
<p><span style="font-weight: 400;">Over the next five months, her dosage was dropped by hundreds of units, measured in morphine milligram equivalents (MME). The consequence: “My health deteriorated so bad,” she said. She developed chest pain “because my heart was not handling the extra pain,” and her blood pressure soared. To address the additional pain caused by the rapid reduction of the single opioid medication, she says she was prescribed </span><i><span style="font-weight: 400;">five </span></i><span style="font-weight: 400;">non-opioid drugs and had to see a gastroenterologist due to the cocktail’s damage to her digestive system.</span></p>
<p><span style="font-weight: 400;">Additionally, her mental health declined. She was unable to provide for her family members the way she’d like. “I basically laid in bed and cried.”</span></p>
<blockquote><p><span style="font-weight: 400;">The new law’s language seems to have spooked her doctor.</span></p></blockquote>
<p><span style="font-weight: 400;">No state law required her doctor to forcibly taper her dosage. But then-Governor Mary Fallin had just signed into law Oklahoma Senate Bill 1446, which imposed new opioid prescribing regulations aimed at discouraging this form of treatment for pain.</span></p>
<p><span style="font-weight: 400;">Fear, in Stewart’s opinion, drove her doctor’s decision. “</span><span style="font-weight: 400;">It had enough big scary words that all the doctors thought that meant they had to reduce every dose under a certain point and try to get as many patients off of pain management as possible.”</span></p>
<p><span style="font-weight: 400;">The bill made prescribing more than 100 MME legally risky for practitioners. Stewart had been on nearly seven times that. The statute only granted greater leniency for patients in “active treatment for cancer,” not former cancer patients like herself. Her pain treatment was working for her, but the new law’s language seems to have spooked her doctor.</span></p>
<p><span style="font-weight: 400;">What happened to Stewart is an increasingly common experience among chronic pain patients across the United States.</span></p>
<p><span style="font-weight: 400;">No formal legal structure incentivizes those registered with the Drug Enforcement Administration (DEA) to handle controlled substances</span><span style="font-weight: 400;">—</span><span style="font-weight: 400;">prescribers, pharmacists and suppliers</span><span style="font-weight: 400;">—</span><span style="font-weight: 400;">to ensure that the people who need opioids can access them. Governments of all scales consider opioids more of a liability than an asset. And in a health care system where profit outweighs people, it’s no wonder that registrants have abandoned pain patients.</span></p>
<p><img decoding="async" class="img-responsive wp-image-11993 aligncenter" src="/wp-content/uploads/2021/04/tamera.jpeg" alt="" width="701" height="482" srcset="/wp-content/uploads/2021/04/tamera.jpeg 800w, /wp-content/uploads/2021/04/tamera-300x206.jpeg 300w, /wp-content/uploads/2021/04/tamera-768x528.jpeg 768w, /wp-content/uploads/2021/04/tamera-376x259.jpeg 376w" sizes="(max-width: 701px) 100vw, 701px" /></p>
<p style="text-align: center;"><em>Tamera Lynn Stewart</em></p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Prescribing Plummeted After CDC Guideline</h4>
<p><span style="font-weight: 400;">Tamera Lynn Stewart, who quickly blossomed into a pain patient advocate, wanted to get to the bottom of her physician’s decision.</span></p>
<p><span style="font-weight: 400;">After seeking explanations from regulators, law enforcement and lawmakers about why prescribers were working in fear, she was led to the Centers for Disease Control and Prevention. In March 2016, the federal health agency published a</span><span style="font-weight: 400;"> “voluntary” and “not prescriptive” </span><a href="https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm#contribAff"><span style="font-weight: 400;">Guideline</span></a><span style="font-weight: 400;"> for primary care physicians treating chronic pain patients (except those receiving active cancer treatment, palliative care and end-of-life care).</span></p>
<p><span style="font-weight: 400;">The Guideline stated that clinicians “</span><span style="font-weight: 400;">should avoid increasing dosage to ≥90 MME/day or carefully justify a decision to titrate dosage to ≥90 MME/day.” </span><span style="font-weight: 400;">Yet nowhere in the document are prescribers told to stop prescribing opioids. Quite the contrary: “Clinicians should consider the circumstances and unique needs of each patient when providing care.”</span></p>
<p><span style="font-weight: 400;">Despite the Guideline’s language, opioid prescribing plummeted in its wake. It had already been declining since 2012, but that only accelerated in the months after publication, according to a</span><a href="https://pubmed.ncbi.nlm.nih.gov/30167651/"><span style="font-weight: 400;"> 2018 study</span></a><span style="font-weight: 400;">.</span></p>
<blockquote><p><span style="font-weight: 400;">&#8220;The messaging that has resulted &#8230; inappropriately suggests opioid prescriptions above certain day or dose limits are outside appropriate medical practice.&#8221;</span></p></blockquote>
<p><span style="font-weight: 400;">“Most states have enacted laws that put arbitrary limits on what a physician or other health care professional can prescribe to a patient in pain,” </span><span style="font-weight: 400;">Dr. Patrice A. Harris, the American Medical Association’s immediate past president and chair of its Opioids Task Force, told </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">.</span><span style="font-weight: 400;"> “As a result, a physician who prescribes above those limits may believe that he or she is breaking the law. Related to that is the messaging that has resulted from the &#8230; guideline that inappropriately suggests opioid prescriptions above certain day or dose limits are outside appropriate medical practice.”</span></p>
<p><span style="font-weight: 400;">Civil rights attorney Kate Nicholson, who recently founded the </span><a href="https://nationalpain.org/"><span style="font-weight: 400;">National Pain Advocacy Center</span></a><span style="font-weight: 400;">, notes the way specific recommended numbers</span><i><span style="font-weight: 400;">—</span></i><span style="font-weight: 400;">like “avoid increasing dosage to” more than 90 MME per day</span><span style="font-weight: 400;">—</span><span style="font-weight: 400;">were mistaken for commandments. “The problem that occurred was the provisions were fairly concrete. [They] had numbers in them that were then seized by the federal and state legislators, by the healthcare system,” Nicholson told </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">.</span></p>
<p><span style="font-weight: 400;">In response to the </span><a href="https://docs.google.com/document/d/1RzQDSppUKhjiAsEmhW2WbTXlP5V8vJ4M_vBPQLKhK_8/edit"><span style="font-weight: 400;">outpouring</span></a><span style="font-weight: 400;"> of testimony and data indicating patient abandonment informed by the CDC’s 2016 Guidelines, the CDC then denounced forced tapers, among other erroneous interpretations, in a 2019</span><a href="https://www.nejm.org/doi/full/10.1056/NEJMp1904190"> <i><span style="font-weight: 400;">New England Journal of Medicine </span></i><span style="font-weight: 400;">article</span></a><span style="font-weight: 400;">. It explicitly stated: “</span><span style="font-weight: 400;">the guideline does not support stopping opioid use abruptly.”</span></p>
<p><span style="font-weight: 400;">Yet even after that, advocates say things haven’t gotten better. </span><span style="font-weight: 400;">“I’m surprised we haven’t had a trickle-down of the clarifications by CDC among policy makers and with pain patients. I haven’t seen any improvement for people on the ground,” said Nicholson. But for Stewart, it’s no surprise. “</span><span style="font-weight: 400;">Everybody thought those 2019 clarifications were just virtue signalling. Nobody took them seriously,” she said.</span></p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Law Enforcement&#8217;s Chilling Effect</h4>
<p><span style="font-weight: 400;">In the fall of 2018, Stewart walked into an Oklahoma State Board of Medical Licensure and Supervision meeting as part of her quest to get answers about her forced taper. The members, she recalled, “</span><span style="font-weight: 400;">said they felt bad for me, and that it was basically the drug cops doing it, not them.” (The Medical Board did not respond to </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">’s request for comment.)</span></p>
<p><span style="font-weight: 400;">It was Oklahoma’s attorney general who pioneered the use of lawsuits seeking billions of dollars from Pharma corporations for their  misleading marketing of opioids. More than 2,000 lawsuits by other prosecutors have also been pursued, yielding spectacular results—like Purdue Pharma pleading guilty to criminal charges in October 2020.</span></p>
<blockquote><p><span style="font-weight: 400;">The DEA has been increasingly conducting criminal and regulatory investigations and bringing lawsuits.</span></p></blockquote>
<p><span style="font-weight: 400;">The fear of law enforcement in chilling prescriptions cannot be overstated. For over a decade, the DEA and attorneys general have ramped up investigations of practitioners, pharmacists and distributors. It’s no wonder that those in the prescribed opioid supply chain have exercised an abundance of caution to the detriment of chronic pain patients.</span></p>
<p><span style="font-weight: 400;">Since 2006, the DEA has been increasingly conducting criminal and regulatory investigations and bringing lawsuits against distributors and pharmacies. Practitioners working in the field of pain medicine are most commonly targeted for criminal sanction, according to a </span><a href="https://scholarlycommons.henryford.com/anesthesiology_articles/89/"><span style="font-weight: 400;">2020 study</span></a><span style="font-weight: 400;">.</span></p>
<p><span style="font-weight: 400;">Advocates have warned of how law enforcement actions are affecting those working to care for chronic pain patients. “Even when medical providers understood that the Guideline was voluntary, they believed they risked punishment or unwanted attention from law enforcement agencies or state medical boards if they maintained patients at high doses,” Human Rights Watch found in a 2019 </span><a href="https://www.hrw.org/sites/default/files/report_pdf/hhr1218_web.pdf"><span style="font-weight: 400;">report</span></a><span style="font-weight: 400;">.</span></p>
<p><span style="font-weight: 400;">Asked to comment on the DEA’s role in obstructing chronic pain patients’ access to treatment, a spokesperson told </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">: “DEA exists to enforce the drug laws of the United States and does not interfere with the practice of medicine. As long as doctors are operating within the normal course of professional practice, can show legitimate medical need for the medications they prescribe, and are not otherwise in violation of the Controlled Substances Act, they would not be subject to law enforcement action.”</span></p>
<p><span style="font-weight: 400;">But a federal government watchdog has confirmed how fear of legal scrutiny has driven health industry practices that make it harder for patients to access their medically-necessary opioids.</span></p>
<p><span style="font-weight: 400;">The Government Accountability Office (GAO) found in a</span><a href="https://www.gao.gov/assets/gao-15-471.pdf"><span style="font-weight: 400;"> 2015 investigation</span></a><span style="font-weight: 400;"> that more than half of 62 distributors surveyed were placing stricter thresholds on opioid orders from practitioners and pharmacies, attributing these actions mostly to the DEA.  Fifty-two out of 84 individual pharmacies and 18 of 29 chain pharmacy corporate offices said that the stricter thresholds limited their ability to supply drugs to those with a legitimate need.</span></p>
<p><span style="font-weight: 400;">One distributor, the GAO noted, “reported it refuses to distribute large volumes of controlled substances to prescribers or pharmacies that specialize in pain management, even if it has no evidence that the prescribers or pharmacies are engaged in diversion.” Because of the DEA’s threat to hold distributors responsible for “diversion” at the prescriber and pharmacist level, the distributor explained that “supplying a large volume of controlled substances to customers with a pain management practice creates too great a risk of being the target of a DEA enforcement action.”</span></p>
<p><span style="font-weight: 400;">The DEA’s lack of clarity about the definition of a “suspicious order” meant that some &#8220;distributors elected to arbitrarily set thresholds for the amount of controlled substances pharmacies could order,” as the GAO summarized in its report.</span></p>
<p><span style="font-weight: 400;">The vagueness has had a trickle-down effect. One pharmacy told the GAO that “DEA has clearly stated that it is not calling for distributor cutoffs (i.e., thresholds), but their distributors have communicated that these changes are made because of fear of DEA enforcement actions, which has led many pharmacies to refuse to fill legitimate prescriptions.”</span></p>
<p><span style="font-weight: 400;">The GAO recommended that the DEA offer suppliers guidance on suspicious order monitoring and reporting—something the DEA has since failed to do. In November 2020, the agency </span><a href="https://www.govinfo.gov/content/pkg/FR-2020-11-02/pdf/2020-21302.pdf"><span style="font-weight: 400;">published</span></a><span style="font-weight: 400;"> a proposed rule updating requirements, but</span><a href="https://www.deachronicles.com/2020/10/dea-creates-two-option-framework-for-reporting-suspicious-orders/"><span style="font-weight: 400;"> it’s unclear</span></a><span style="font-weight: 400;"> how it will impact suppliers’ business practices.</span></p>
<blockquote><p><span style="font-weight: 400;">The DEA’s method for measuring “success” included simply tracking the number of investigations conducted and the number of sanctions imposed.</span></p></blockquote>
<p><span style="font-weight: 400;">Even with that potential clarification, the damage to how pharmacies operate has been done. In one of the highest-profile cases, Walmart, the </span><a href="https://www.statista.com/statistics/734171/pharmacies-ranked-by-rx-market-share-in-us/"><span style="font-weight: 400;">fifth largest</span></a><span style="font-weight: 400;"> pharmacy chain in the country, installed in 2018 a block on “suspicious” prescribers and a seven-day, 50 MME-per-day limit on initial opioid prescriptions for acute issues. That came after the Department of Justice considered criminally indicting the world’s largest company for filling “suspicious” prescriptions.</span></p>
<p><span style="font-weight: 400;">A </span><a href="https://www.documentcloud.org/documents/6818266-2019-09-27-Letter-From-K-Hewitt-to-G-Eyler-Final.html"><span style="font-weight: 400;">2019 letter</span></a><span style="font-weight: 400;"> to the DoJ from an attorney representing Walmart demonstrates that the company’s “aggressive policy,” </span><a href="https://corporate.walmart.com/media-library/document/walmart-efforts-to-address-opioid-crisis/_proxyDocument?id=00000175-51cb-dca8-ad77-73cfbf9c0000"><span style="font-weight: 400;">supposedly</span></a><span style="font-weight: 400;"> modeled on the 2016 CDC guidelines, was made to reassure investigators that they were doing their part, even if it meant “significant blowback” from state Boards of Pharmacy. According to the letter, three states sent letters warning that the policies were impermissible. In December 2020, DoJ </span><a href="https://www.justice.gov/opa/pr/department-justice-files-nationwide-lawsuit-against-walmart-inc-controlled-substances-act"><span style="font-weight: 400;">sued</span></a><span style="font-weight: 400;"> Walmart anyway.</span></p>
<p><span style="font-weight: 400;">Despite the resources poured into these investigations, there’s no evidence supporting their effectiveness at stopping diversion—an activity criminalized on the premise that using unprescribed pharmaceuticals is undesirable, despite their being far safer than the unpredictable illicit opioid supply driving fatalities. In 2011, in response to the agency’s escalating enforcement actions, the GAO </span><a href="https://www.gao.gov/products/gao-11-744"><span style="font-weight: 400;">found</span></a><span style="font-weight: 400;"> the DEA did not have a system in place to accurately measure any impact on diversion. The DEA’s method for measuring “success” included simply tracking the number of investigations conducted and the number of sanctions imposed, among other things.</span></p>
<p><span style="font-weight: 400;">In a letter responding to the watchdog’s findings, Joseph Rannazzisi, the head of DEA&#8217;s Diversion Control office, made two things clear: 1) the “vast majority of registrant inspections do not uncover serious violations of the [Controlled Substances Act]” and 2) “it is impossible” to measure whether anti-diversion efforts are actually working. Instead, he wrote, “the specter of increased scheduled regulatory investigations” has a “deterrent effect that cannot be measured by raw data.”</span></p>
<p><span style="font-weight: 400;">In other words, the DEA had a hunch that scaring people with policing would make a difference.</span></p>
<p><span style="font-weight: 400;">Years before the escalating prosecutions, Dr. Scott Fishman, now the director of Center for Advancing Pain Relief at University of California, Davis, outlined the impact of the kind of fear mongering that Rannazzisi later championed.</span></p>
<p><span style="font-weight: 400;">“It seems that all you may need to change physician behavior is to simply advance intimidating policy statements or even initiate a few physician investigations that begin with a visit from DEA field agents dressed in flak jackets who carry weapons,” Dr. Fishman </span><a href="https://academic.oup.com/painmedicine/article/7/4/360/1937923"><span style="font-weight: 400;">wrote</span></a><span style="font-weight: 400;"> in 2006. “Physician fear of regulatory scrutiny may not always be based on real threats, but they lead to real changes in prescribing behaviors that can substantially impair the treatment of patients in pain.”</span></p>
<p>&nbsp;</p>
<h4 style="text-align: center;"><span style="font-weight: 400;">Prescription Drug Monitoring Programs</span></h4>
<p><span style="font-weight: 400;">When Stewart sought answers from the Oklahoma Medical Board, they clarified that “t</span><span style="font-weight: 400;">he law doesn’t say they have to take me off of it,” she recounted, and that she should therefore just “find a new doctor.”</span></p>
<p><span style="font-weight: 400;">But it’s not that simple. Although Stewart says she eventually was able to get her dosage increased after her cardiologist and gastro-enterologist sent a letter to her pain management doctor urging the reversal, a </span><a href="https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/add.14394"><span style="font-weight: 400;">wave </span></a><span style="font-weight: 400;">of reports from chronic pain patients say that practitioners willing to prescribe the dosage they need are increasingly scarce.</span></p>
<p><span style="font-weight: 400;">In large part, the stonewalling has been facilitated by prescription drug monitoring programs (PDMP)—state-run databases, the use of which is </span><span style="font-weight: 400;">available to and, as of October 2021, required of practitioners and pharmacists to track controlled substance prescriptions. If Missouri approves a </span><a href="https://www.senate.mo.gov/21info/BTS_Web/Bill.aspx?SessionType=R&BillID=54228843"><span style="font-weight: 400;">bill</span></a><span style="font-weight: 400;"> to start a PDMP, all 50 states will have one. PDMP data are monitored by law enforcement for investigations of both “pill mills” and “doctor shoppers.&#8221;</span></p>
<blockquote><p><span style="font-weight: 400;">“That </span><span style="font-weight: 400;">data is context-free &#8230; You can’t assume or conclude anything about it.”</span></p></blockquote>
<p><span style="font-weight: 400;">The information provided by PDMPs is limited: drug, dose days and units, prescriber and pharmacist, usually. It does not account for </span><i><span style="font-weight: 400;">why </span></i><span style="font-weight: 400;">a patient may be prescribed multiple or high-dosage opioid prescriptions from one or more practitioners. “That </span><span style="font-weight: 400;">data is context-free,” said Dr. Terri Lewis, a clinical educator who researches PDMPs. “It doesn’t really lend itself to analytics: You can’t assume or conclude anything about it,” such as whether the personal is “doctor-shopping,” “because that’s not what you’re collecting.”</span></p>
<p><span style="font-weight: 400;">Amid a climate of fear cultivated by law enforcement, practitioners have denied care to patients simply on the results of a PDMP search, which </span><a href="/how-helpful-or-harmful-are-prescription-drug-monitoring-programs/"><span style="font-weight: 400;">offer no resources </span></a><span style="font-weight: 400;">or referrals to those suspected of having an opioid use disorder.</span></p>
<p><span style="font-weight: 400;">“PDMP surveillance provokes prescribers to cut loose chronic pain and other complex patients for whom opioids and other suspect controlled substances are indicated,” Jennifer Oliva, a law professor and director of the Center for Health & Pharmaceutical Law at Seton Hall University, told </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">. “Prescribers engage in such behavior to avoid DEA investigation and professional licensing board scrutiny. Research further teaches that prescription surveillance puts patient lives at risk by incentivizing opioid patients to opt out of the health-care delivery system to avoid law enforcement surveillance and possible prosecution.”</span></p>
<p><span style="font-weight: 400;">This abandonment of care for chronic pain patients has led to devastating outcomes: an alarming number of suicides and fatal overdoses, according to a</span><a href="https://www.bmj.com/content/368/bmj.m283"><span style="font-weight: 400;"> 2020 study</span></a><span style="font-weight: 400;">. Numerous anecdotal reports of patients taking their own lives have proliferated online—a major reason for the CDC’s 2019 clarification. For those seeking to treat their pain when medical professionals won’t, the more-accessible criminalized market exposes them to an unpredictable supply, often cut with highly potent opioids like fentanyl, and with other depressants that drive up overdose risk.</span></p>
<p><span style="font-weight: 400;">Practitioners’ problematic conceptions or perceptions can play a role in whether they abandon a chronic pain patient after querying a PDMP. One faulty assumption promoted by regulators is that a higher dosage means greater risk of an overdose. Although there is a risk relationship between dosage and overdose, the assumption that dosage </span><i><span style="font-weight: 400;">predicts</span></i><span style="font-weight: 400;"> overdose misunderstands when overdoses actually occur among prescribed patients—as three physician-advocates explained in a </span><a href="https://stefankertesz.medium.com/whats-wrong-with-just-counting-the-patients-on-high-dose-opioids-and-calling-that-bad-care-3f585ceac22e"><span style="font-weight: 400;">2018 letter </span></a><span style="font-weight: 400;">to the Center for Medicaid and Medicare after the agency proposed negatively rating the performance of physicians by the number of high-dosage prescriptions written. As they found through examining a number of studies, it’s patients on lower doses (under 90 MME) who most frequently end up fatally overdosing, not those on the higher doses targeted by laws and regulations.</span></p>
<p><span style="font-weight: 400;">Stigma against and misconceptions about people living with substance use disorders (SUD) also influence practitioner decision-making. “I don’t want heroin addicts in my waiting room,” </span><span style="font-weight: 400;">Dr. Eric Schnakenberg, a New York </span><span style="font-weight: 400;">family medicine doctor, previously </span><a href="/how-helpful-or-harmful-are-prescription-drug-monitoring-programs/"><span style="font-weight: 400;">told</span></a> <i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;"> in explaining why he uses PDMPs. Physical dependence (experiencing withdrawal when a substance is removed) is not the same as SUD, defined as continuing to consume drugs despite negative consequences. Yet that distinction can be lost on practitioners making clinical determinations merely off of PDMP-reported dose days and units.</span></p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Racism and Bias</h4>
<p><span style="font-weight: 400;">Other subjective factors have been shown to play a role in PDMP-influenced decision-making. A </span><a href="https://academic.oup.com/painmedicine/article/18/6/1063/2433392"><span style="font-weight: 400;">2016 study</span></a><span style="font-weight: 400;"> found that a patient’s perceived honesty and intent played a role in discharging them from care. The researchers flagged for further study the need “</span><span style="font-weight: 400;">to examine clinician interpretation of apparent patient dishonesty and to determine the appropriate level of influence of this factor in formulating prescribing decisions.”</span></p>
<p><span style="font-weight: 400;">Whose pain can be trusted is shaped by racist stereotypes. “Black Americans are seen as drug seekers and not as a patient who wants to remedy their pain,” said Dr. Tamara Baker, a psychiatry professor and an expert on racial disparities in pain management, referencing the broad literature demonstrating that Black pain is taken less seriously than others’.</span></p>
<p><span style="font-weight: 400;">The racist idea that Black people experience less pain </span><a href="https://www.nytimes.com/interactive/2019/08/14/magazine/racial-differences-doctors.html"><span style="font-weight: 400;">dates back</span></a><span style="font-weight: 400;"> to chattel slavery, and appears to be alive and well. In a </span><a href="https://pubmed.ncbi.nlm.nih.gov/22239747/"><span style="font-weight: 400;">systematic review of 20 years of data</span></a><span style="font-weight: 400;">, researchers found that Black patients were 29 percent less likely than whites to receive treatment with opioids for similar painful conditions. Another racist idea, that Black people are seeking drugs unnecessarily, also seems to be illustrated by the numbers. Black patients seeking emergency medical attention for issues not readily verifiable, like abdominal or back pain, were far less likely to be administered or prescribed opioids compared to their white counterparts, a 2016 study </span><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976905/"><span style="font-weight: 400;">found</span></a><span style="font-weight: 400;">.</span></p>
<blockquote><p><span style="font-weight: 400;"> “We’re not believed when we say we are in pain, generally thought to be lying or overestimating our pain and written off as disingenuous.&#8221;</span></p></blockquote>
<p><span style="font-weight: 400;">Advocates for patients living with sickle cell disease—an inherited disorder </span><a href="https://www.cdc.gov/ncbddd/sicklecell/data.html"><span style="font-weight: 400;">most common among Black people</span></a><span style="font-weight: 400;"> and which can involve recurring episodes of acute pain as well as chronic pain—say that the confluence of racism and opioid prescribing crackdown has harmed their health.</span></p>
<p><span style="font-weight: 400;">“</span><span style="font-weight: 400;">SCD patients are often undertreated, treated as drug seekers and many times ignored when they say they’re in pain,” said Jemela Williams, an SCD advocate and a Black woman herself living with the condition. </span><a href="https://pubmed.ncbi.nlm.nih.gov/16483093/"><span style="font-weight: 400;">Doctors</span></a><span style="font-weight: 400;"> and </span><a href="https://d1wqtxts1xzle7.cloudfront.net/51471101/apnr.2001.2678320170122-22666-md63eq.pdf?1485127019=&response-content-disposition=inline%3B+filename%3DNurses_attitudes_and_practices_in_sickle.pdf&Expires=1619376000&Signature=XPM6J65fR0s-TtxtviO6QOIGbuKcjkSQo1ZCnX0PrsPbnLokvUiWKx8e8pv54G39KlCfieYxeQ3mTadw16MQ5BUIVTCHT9s4eAa6qsBQA41fzciHgPzCpVdvzaKjyOFLLiKIuyOl8pxNj~qWFWu2jxzqvUdj973VJMB56HgEQnRwfsKZ-bEK0lMZmAzuQSnwBUOY730LX8GkLmIXKJ0AEytNq2OSmZi31MChzZLiHiPPndsrTOBLMSrEsHWSBevlHt8qIHxPnXVHZ0vp2AP5Ky3oFAc6ZxF8QscpRtFxVzAT3DsGH4RjLLhPfYaHBTrcwfunerpqDAnWZr9c3jXfpg__&Key-Pair-Id=APKAJLOHF5GGSLRBV4ZA"><span style="font-weight: 400;">nurses</span></a><span style="font-weight: 400;"> often believe SCD patients are more likely to become “addicted” than other patient populations, resulting in reported reluctance to administer high dosages. Black SCD patients have </span><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2734070"><span style="font-weight: 400;">reported</span></a><span style="font-weight: 400;"> that they had more difficulty accessing their needed dosage due to prescribing restrictions, stigma and racist bias after the 2016 CDC guidelines.</span></p>
<p><span style="font-weight: 400;">“A lot of the reasons we face these barriers has a lot to do with race,” Williams told </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">. “We’re not believed when we say we are in pain, generally thought to be lying or overestimating our pain and written off as disingenuous if we’re not acting the way that that medical professional thinks we should be if we are hurting.”</span></p>
<p><span style="font-weight: 400;">At first glance an increasingly-utilized artificial intelligence program—NarxCheck, a proprietary algorithm that produces a risk score (NarxScore) based on PDMP data—bears the promise of avoiding messy human bias. But Lewis and her colleagues are concerned its use will further disrupt chronic pain patients’ access. Forty-three jurisdictions  and companies, like Walmart, have adopted NarxCheck, even though the Food and Drug Administration has not evaluated it and nor has it been subjected to peer review.</span></p>
<p><span style="font-weight: 400;">Originally patented in 2011, the algorithm is largely based on the decontextualized data points visible to PDMP users and already vulnerable to erroneous human assumptions–––MME, number of providers and pharmacies, potentiating drugs, and number of overlapping prescription days, according to a </span><a href="https://apprisshealth.com/wp-content/uploads/sites/2/2017/02/NARxCHECK-Score-as-a-Predictor.pdf"><span style="font-weight: 400;">paper</span></a><span style="font-weight: 400;"> by Appriss, the company bearing the rights to NarxCheck. It also includes data points that Oliva, who </span><a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3768774"><span style="font-weight: 400;">studies</span></a><span style="font-weight: 400;"> PDMPs’ discriminatory consequences, warns could exacerbate racial and gender disparities in pain treatment.</span></p>
<p><span style="font-weight: 400;">“NarxCare has begun to incorporate information from non-prescribing data sets</span><span style="font-weight: 400;">—</span><span style="font-weight: 400;">such as criminal and sexual trauma history</span><span style="font-weight: 400;">—</span><span style="font-weight: 400;">into its risk generating algorithms that are sure to disparately impact particular patient populations who have a long history of discriminatory treatment in the pain management setting,” she said.</span></p>
<blockquote><p><span style="font-weight: 400;">The validity of NarxCheck is questionable, for Lewis, because of the data from which it was built.</span></p></blockquote>
<p><span style="font-weight: 400;">NarxCheck stakes the threshold of risk at 90 MME per day, meaning those exceeding it will be predicted to be more likely to overdose. And it produces a numerical score, from 000 to 999, that Lewis says could inappropriately replace clinical judgement, as PDMPs have in some cases.</span></p>
<p><span style="font-weight: 400;">Additionally, the validity of NarxCheck is questionable, for Lewis, because of the data from which it was built: a sample of opioid-prescribed patients from Ohio’s PDMP who fatally overdosed </span><i><span style="font-weight: 400;">and </span></i><span style="font-weight: 400;">were suspected of “opioid misuse.” This begs the question of whether it is generalizable to people who do not have a problematic relationship with opioids, such as many chronic pain patients.</span></p>
<p><span style="font-weight: 400;">“</span><span style="font-weight: 400;">Here’s the problem: If you’re sick and have been using your medicine for a while, you’re going to be flagged,” Lewis said. And there’s emerging evidence to back that up. Northeastern University researchers </span><a href="http://www2.nber.org/conferences/2020/SI%20subs/main_draft23.pdf"><span style="font-weight: 400;">developed</span></a><span style="font-weight: 400;"> a machine learning model using data similar to NarxCheck to predict opioid use disorder among patients prescribed opioids. Their model targeted patients living with “complex chronic pain conditions and other burdensome comorbidities,” despite such patients not being likely to enjoy benefits from reduced prescribing, consequentially suggesting that the ways in which comparable risk-scoring algorithms have been constructed may be biased.</span></p>
<p><span style="font-weight: 400;">Through her advocacy work, Nicholson has heard anecdotes about NarxCheck’s misidentification of chronic pain patients. “We’ve seen a patient with a bad NarxScore because they have multiple doctors. They take that as doctor shopping, but there are lots of innocent reasons, and the problem is they overreach,” said Nicholson. “These algorithms assign them scores that can lead to turning them away.”</span></p>
<p><span style="font-weight: 400;">Appriss did not respond to </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">’s request for comment.</span></p>
<p><span style="font-weight: 400;">Taking together all the factors chilling opioid prescribing, Lewis believes we’re missing the point: empowering people to keep themselves safe, instead of making paternalistic judgements.</span></p>
<p><span style="font-weight: 400;">“</span><span style="font-weight: 400;">We know a lot of people use street drugs properly, and they manage their risk very well,” she pointed out. “But patients’ individual risk management strategies, like taking their medicine with others if opioid naive [or] having naloxone on hand, won’t show up [in PDMPs or NarxScores] because it’s not counted!”</span></p>
<p>&nbsp;</p>
<h4 style="text-align: center;"><span style="font-weight: 400;">&#8220;Death by a Thousand Paper Cuts&#8221;</span></h4>
<p><i><span style="font-weight: 400;">Once the horse is out of the barn, you can’t put it back</span></i><span style="font-weight: 400;">.</span></p>
<p><span style="font-weight: 400;">That’s what sitting Oklahoma State Senator Rob Standridge allegedly told Tamera Lynn Stewart when she asked why he kept pursuing stricter opioid prescribing laws even as chronic pain patients suffered as a result. She had come to give him an obituary of a patient who had taken their own life. Senator Standridge did not respond to </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">’s request for comment.</span></p>
<p><span style="font-weight: 400;">It’s been two years since the CDC denounced misapplications of its Guideline—yet legislators continue to take the agency’s 2016 recommendations as orders to be codified.</span></p>
<p><span style="font-weight: 400;">There surely are numerous reasons why politicians continue passing laws at odds with a growing public health consensus. For one, the </span><a href="https://pubmed.ncbi.nlm.nih.gov/28402482/"><span style="font-weight: 400;">flawed narrative</span></a><span style="font-weight: 400;"> of overprescribing as a driver of the overdose crisis has “been on non-stop” in our media and culture, said Kate Nicholson. She also thinks “</span><span style="font-weight: 400;">It’s a good narrative for politicians,” namely that they’re protecting vulnerable patients from predatory corporations.</span></p>
<p><span style="font-weight: 400;">And then, of course, there are the lobbyists. One such anti-opioid group is Physicians for Responsible Opioid Prescribing (PROP), whose VP for federal affairs, Dr. Andrew Kolodny, was a star witness in the Oklahoma lawsuit against Johnson & Johnson and has testified before Congress on the so-called “opioid crisis.” Publicly, PROP has remained steadfast in supporting the CDC’s 2016 Guideline. Most recently, the group confronted the head of the American Medical Association for </span><a href="https://searchlf.ama-assn.org/undefined/documentDownload?uri=%2Funstructured%2Fbinary%2Fletter%2FLETTERS%2F2020-6-16-Letter-to-Dowell-re-Opioid-Rx-Guideline.pdf"><span style="font-weight: 400;">urging</span></a><span style="font-weight: 400;"> “governors and state legislators to take action [to] remove …. arbitrary dose, quantity and refill restrictions on controlled substances.” In a </span><a href="http://www.supportprop.org/wp-content/uploads/2021/02/PROP-AMA-Letter-.pdf"><span style="font-weight: 400;">February 2021 letter</span></a><span style="font-weight: 400;">, PROP alleged that AMA’s recommendation is “simply a repeat of the pharmaceutical industry’s playbook that led to an epidemic of opioid use disorder,” instead of one informed by chronic pain patients’ lived experiences and empirical evidence.</span></p>
<blockquote><p><span style="font-weight: 400;">With waves of new anti-opioid bills being drafted, Stewart and her advocate colleagues have their work cut out.</span></p></blockquote>
<p><span style="font-weight: 400;">Despite the misinformation that remains on Capitol Hill and at state capitols across the country, some progress is being made. For example, Kate Nicholson and a slew of other advocates successfully had removed from </span><a href="https://www.portman.senate.gov/sites/default/files/2021-03/TAM21688.pdf"><span style="font-weight: 400;">CARA 3.0</span></a><span style="font-weight: 400;">, prior to its introduction in March 2021, a section that would have installed a </span><span style="font-weight: 400;">three-day limit on initial opioid prescriptions for acute pain across the country.</span></p>
<p><span style="font-weight: 400;">Back in Oklahoma, Stewart helped get </span><a href="http://www.oklegislature.gov/BillInfo.aspx?Bill=sb57"><span style="font-weight: 400;">Senate Bill 57</span></a><span style="font-weight: 400;"> passed through both houses of the state legislature, though final approval of amendments and the governor’s signature are still pending. Nevertheless, when </span><i><span style="font-weight: 400;">Filter </span></i><span style="font-weight: 400;">spoke with her, she was excited: Patients receiving aftercare for cancer would be eligible for exemption from the 2018 law that sparked her forced taper. The bill also prohibits the misinterpretation of the law establishing the state’s PDMP to mean that it “require[s] a practitioner to limit or forcibly taper a patient on opioid therapy.”</span></p>
<p><span style="font-weight: 400;">With waves of new anti-opioid bills and the new CDC guidelines currently being drafted, Stewart and her advocate colleagues have their work cut out for them.</span></p>
<p><span style="font-weight: 400;">Stewart has a phrase for both how chronic pain patients have been harmed by the opioid prescribing crackdown, and the amount of work needed to undo that harm: “death by a thousand paper cuts.’’ </span></p>
<p>&nbsp;</p>
<hr />
<p>&nbsp;</p>
<p><em>Top photograph by <a href="https://unsplash.com/@puregraphics?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Preslava Glushkova</a> on <a href="https://unsplash.com/s/photos/pain?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Unsplash</a>. Other photograph courtesy of Tamera Lynn Stewart.</em></p>
<p><em><a href="https://www.rstreet.org/" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?hl=en&q=https://www.rstreet.org/&source=gmail&ust=1619646110982000&usg=AFQjCNF8lyVh-qip85Htl4_u2Hk-1PtP5g">R Street Institute</a> supported the production of this article through a restricted grant to The Influence Foundation, which operates </em>Filter<em>.</em></p>
<p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=%2Fpain-patients-opioids-fear%2F&linkname=How%20Fear%2C%20Misinformation%2C%20Stigma%20Have%20Devastated%20US%20Pain%20Patients" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=%2Fpain-patients-opioids-fear%2F&linkname=How%20Fear%2C%20Misinformation%2C%20Stigma%20Have%20Devastated%20US%20Pain%20Patients" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_email" href="https://www.addtoany.com/add_to/email?linkurl=%2Fpain-patients-opioids-fear%2F&linkname=How%20Fear%2C%20Misinformation%2C%20Stigma%20Have%20Devastated%20US%20Pain%20Patients" title="Email" rel="nofollow noopener" target="_blank"></a></p><p>The post <a href="/pain-patients-opioids-fear/">How Fear, Misinformation, Stigma Have Devastated US Pain Patients</a> appeared first on <a href="/">Filter</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>&#8220;Devastating&#8221; West Virginia Law Could Practically End Syringe Provision</title>
		<link>/west-virginia-syringe-bill/</link>
		
		<dc:creator><![CDATA[Umme Hoque]]></dc:creator>
		<pubDate>Mon, 26 Apr 2021 14:04:22 +0000</pubDate>
				<category><![CDATA[FilterMag]]></category>
		<category><![CDATA[Politics + Legalization]]></category>
		<category><![CDATA[drug policy reform]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[homelessness]]></category>
		<category><![CDATA[opioids]]></category>
		<category><![CDATA[syringes]]></category>
		<guid isPermaLink="false">/?p=11979</guid>

					<description><![CDATA[<p>Over 1,200 West Virginians died of overdose in 2020, new data show—a 45 percent increase from 2019. This coincides with ...</p>
<p>The post <a href="/west-virginia-syringe-bill/">&#8220;Devastating&#8221; West Virginia Law Could Practically End Syringe Provision</a> appeared first on <a href="/">Filter</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span class="wpsdc-drop-cap">O</span>ver 1,200 West Virginians died of overdose in 2020, <a href="https://mountainstatespotlight.org/2021/04/21/west-virginia-overdose-deaths-set-new-record-amid-pandemic/">new data show</a><span style="font-weight: 400;">—a </span>45 percent increase from 2019. This coincides with an <a href="/hiv-outbreak-wv-syringe-programs/"><span style="font-weight: 400;">historic HIV outbreak</span></a><span style="font-weight: 400;"> that is rapidly spreading across the state. As these numbers grow, Governor Jim Justice on April 15 signed a bill that health experts argue will lead to further cases and deaths. Senate Bill 334 (SB 334) could practically end syringe service programs (SSP) in the state.</span></p>
<p><span style="font-weight: 400;">SB 334 requires all new and the existing SSP to apply for certification and offer multiple harm reduction services—including HIV testing, treatment referrals and overdose prevention education—not just syringe provision. Syringe provision will be limited to one-to-one exchange. </span><span style="font-weight: 400;">Programs will now also have to show the written support of the city and county commissions—a severe challenge in a state where many politicians see harm reduction as a political issue, not a public health solution. </span></p>
<p><span style="font-weight: 400;">In total, the bill forces SSP to operate in a manner that over 300 West Virginia public health experts, medical professionals, nurses, educators and advocates argued in a </span><a href="https://www.acluwv.org/sites/default/files/field_documents/letter_to_governor_justice.pdf"><span style="font-weight: 400;">letter</span></a><span style="font-weight: 400;"> to the governor is “in direct contravention of CDC guidance; guidance which is based on 30 years of peer-reviewed science.” </span></p>
<p><span style="font-weight: 400;">“SB 334 is incredibly restrictive legislation that seems clearly designed to outlaw as many syringe service programs as possible,” Loree Stark, legal director at the American Civil Liberties Union of West Virginia (ACLU-WV) told </span><i><span style="font-weight: 400;">Filter. </span></i><span style="font-weight: 400;">“The reasoning behind the bill has never made sense. All of this is not in the interest of public health.” </span></p>
<p><span style="font-weight: 400;">In spite of calls for the governor to veto the bill, he signed it mere hours after it hit his desk. Rule-making is still underway, so some terms and definitions are still in development. For now, the future of programs across the state is </span><a href="https://www.wvnews.com/news/wvnews/marion-county-harm-reduction-program-to-close-taylor-countys-under-review-after-passage-of-w/article_4798c83b-afa9-5a95-be36-53428605f133.html"><span style="font-weight: 400;">tenuous</span></a><span style="font-weight: 400;"> at best, with some saying they will close.</span></p>
<p><span style="font-weight: 400;">“It’s really devastating. Very few facilities have the funds to comply with the laundry list of requirements,” Stark said. “They will have to close down or risk getting fined by the licensing body.” </span></p>
<blockquote><p><span style="font-weight: 400;">“We’re leaving health decisions in the hands of politicians.”</span></p></blockquote>
<p><span style="font-weight: 400;">Requiring local officials to support harm reduction programs can be an especially challenging requirement in the highly conservative state. An recent HIV outbreak in Kanawha County, home of West Virginia’s capitol, Charleston, was called the </span><a href="https://apnews.com/article/charleston-west-virginia-united-states-a858a2c1c9a1edb0a8a82bb57d37bbfc"><span style="font-weight: 400;">most concerning</span></a><span style="font-weight: 400;"> in the country by the CDC. </span><a href="https://www.wvpublic.org/health-science/2021-04-05/kanawha-commissioners-question-hiv-label-for-the-county-from-cdc"><span style="font-weight: 400;">Response</span></a><span style="font-weight: 400;"> by local and federal representatives, including Senator Joe Manchin, was to call into question the CDC’s statement—not to address the issue of HIV increases. </span></p>
<p><span style="font-weight: 400;">To make matters worse, Charleston City Council passed</span><a href="https://www.wvpublic.org/health-science/2021-04-20/charleston-approves-new-regulations-for-needle-exchanges"><span style="font-weight: 400;"> on April 20</span></a><span style="font-weight: 400;"> legislation that is even more restrictive for harm reduction programs operating in the city. The council added misdemeanor criminal charges to anyone distributing syringes, equating to fines, fees and potential incarceration for nurses and doctors supporting drug users. </span></p>
<p><span style="font-weight: 400;">The legislation passed with nearly unanimous support of the local council, in spite of the fact that 68 percent of residents in the county </span><a href="/charleston-west-virginia-syringe-exchange/"><span style="font-weight: 400;">stated support</span></a><span style="font-weight: 400;"> for harm reduction programs.</span></p>
<p><span style="font-weight: 400;">“We’re leaving health decisions in the hands of politicians,” Stark said. </span></p>
<p><span style="font-weight: 400;">For opponents of SB 334, the fight is not over. Gaps in the legislation are problematic and <a href="https://www.acluwv.org/sites/default/files/field_documents/aclu-wv_msj_letter_re_334_constitutional_concerns.pdf">potentially unconstitutional</a>, they note, including requiring program participants to have West Virginia identification. This is additionally a practical challenge for unhoused communities and those who cannot get updated documents because of the pandemic. </span></p>
<p><span style="font-weight: 400;">The bill also lacks due process for commissions to respond to harm reduction programs seeking a letter of support per the requirements. With no mechanisms for accountability, there is a chance programs may never be responded to and could languish at the whim of local representatives.  </span></p>
<p><span style="font-weight: 400;">Advocates and experts remain committed to ensuring drug users can get evidence-based support. </span></p>
<p><span style="font-weight: 400;">“We’re looking at how we can proceed to protect not only the harm reduction programs but also participants and public health. People are already sick, and more people will get sick,” Stark said.</span></p>
<p><span style="font-weight: 400;">“West Virginians are being failed by every level of government.”</span></p>
<p>&nbsp;</p>
<hr />
<p>&nbsp;</p>
<p><em>Photograph by Carol M. Highsmith via <a href="https://en.wikipedia.org/wiki/File:The_West_Virginia_Capitol_in_Charleston_LCCN2015631770.tif">Library of Congress/Wikipedia</a></em></p>
<p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=%2Fwest-virginia-syringe-bill%2F&linkname=%E2%80%9CDevastating%E2%80%9D%20West%20Virginia%20Law%20Could%20Practically%20End%20Syringe%20Provision" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=%2Fwest-virginia-syringe-bill%2F&linkname=%E2%80%9CDevastating%E2%80%9D%20West%20Virginia%20Law%20Could%20Practically%20End%20Syringe%20Provision" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_email" href="https://www.addtoany.com/add_to/email?linkurl=%2Fwest-virginia-syringe-bill%2F&linkname=%E2%80%9CDevastating%E2%80%9D%20West%20Virginia%20Law%20Could%20Practically%20End%20Syringe%20Provision" title="Email" rel="nofollow noopener" target="_blank"></a></p><p>The post <a href="/west-virginia-syringe-bill/">&#8220;Devastating&#8221; West Virginia Law Could Practically End Syringe Provision</a> appeared first on <a href="/">Filter</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Drug Decriminalization in Oregon: How&#8217;s It Going So Far?</title>
		<link>/drug-decriminalization-oregon/</link>
		
		<dc:creator><![CDATA[Morgan Godvin]]></dc:creator>
		<pubDate>Thu, 22 Apr 2021 11:59:39 +0000</pubDate>
				<category><![CDATA[FilterMag]]></category>
		<category><![CDATA[Politics + Legalization]]></category>
		<category><![CDATA[addiction]]></category>
		<category><![CDATA[criminal injustice]]></category>
		<category><![CDATA[decriminalization]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[overdose]]></category>
		<guid isPermaLink="false">/?p=11959</guid>

					<description><![CDATA[<p>Tanesia DeMacon is no stranger to jail. She estimates she was arrested no fewer than 15 times, starting at the ...</p>
<p>The post <a href="/drug-decriminalization-oregon/">Drug Decriminalization in Oregon: How&#8217;s It Going So Far?</a> appeared first on <a href="/">Filter</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span class="wpsdc-drop-cap">T</span>anesia DeMacon is no stranger to jail. She estimates she was arrested no fewer than 15 times, starting at the age of 18 and continuing throughout her 20s.</p>
<p>“I used to joke that county jail was school for the ‘hood,” says DeMacon, an African American woman from East Portland, Oregon. “I just started meeting more and more people who were into more and more things. Honestly, it taught me how to do more criminal activity.”</p>
<p>Like so many, her constant encounters with the system went hand in hand with her heroin addiction. She recounts having overdosed five times, resuscitated each time by police or EMTs with naloxone. Once it was a grocery store bathroom, another time a 24-hour diner. Somehow, she was always found.</p>
<p>Now 30, DeMacon has grieved for more of her friends than most people twice her age. At least 10 people she knows have fatally overdosed. She fears more deaths are on the horizon.</p>
<blockquote><p>“I was on probation. I could never pass a drug test. It’s stressful being in that situation because you’re always possibly going to go to jail.&#8221;</p></blockquote>
<p>“In jail, they don’t care about you,” she says, her voice tinged with cynicism and sadness. “You’re just another number. They don’t even treat us like humans. I’ve literally been called ‘animal’ by a CO.”</p>
<p>She sought substance use disorder treatment many times, only managing to “graduate” once at a center that emphasized healing from past traumas. She used heroin again an hour later. On her other eight attempts, she didn’t last more than four days before leaving.</p>
<p>Now, she says, she “fell in love” with life. She left her addiction behind and is starting school in the fall, though she worries that her criminal record could limit her options. She has decided to major in political science, since it was politics—of which the criminal justice system is a direct outcropping—that wreaked so much havoc on her young life.</p>
<p>“I was on probation. I could never pass a drug test,” she says. “It’s stressful being in that situation because you’re always possibly going to go to jail. You have to check in with your PO, but if you do that, you’re probably going to jail as well [because of the urine test].”</p>
<p>“So, do you just not check in and take the warrant?”</p>
<p><img loading="lazy" decoding="async" class="img-responsive size-full wp-image-11960 aligncenter" src="/wp-content/uploads/2021/04/Screenshot-2021-04-21-at-16.45.37.png" alt="" width="581" height="554" srcset="/wp-content/uploads/2021/04/Screenshot-2021-04-21-at-16.45.37.png 581w, /wp-content/uploads/2021/04/Screenshot-2021-04-21-at-16.45.37-300x286.png 300w, /wp-content/uploads/2021/04/Screenshot-2021-04-21-at-16.45.37-376x359.png 376w" sizes="auto, (max-width: 581px) 100vw, 581px" /></p>
<p style="text-align: center;">Tanesia DeMacon</p>
<p>&nbsp;</p>
<p>For decades, that was the paradox faced by Oregonians with substance use disorders (SUD) who had been arrested. You were jailed, put on my probation, and if you provided a positive urine screen, or transgressed on one of countless other technicalities, you were violated and sent right back to jail.</p>
<p>Although the drug war is global, the United States remains an outlier among wealthy nations for the punitive harshness of its drug policy. Out of more than 1.5 million drug arrests made in 2019, the vast majority—<a href="https://www.drugpolicyfacts.org/chapter/crime_arrests">86.7 percent</a>—were for simple possession. Despite a growing recognition of its racist origins and implementation, two decades into the 21st century, the War on Drugs rages on.</p>
<p>But in November, Oregon became the first US state to try a different approach than the one that has harmed DeMacon and countless others—including many people who do <i>not</i> have SUD—when voters passed Measure 110, decriminalizing small-scale possession of all drugs.</p>
<p>Measure 110 also diverts a portion of tax revenue from the cannabis industry, which Oregon legalized back in 2014, to SUD treatment.</p>
<p>The passage of the measure made history. It also brought controversy close on its heels, as lawmakers and wider society grapple with interpretations, funding and challenging timelines.</p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Decriminalization in Practice</h4>
<p>The decriminalization element of Measure 110 went into effect on February 1.</p>
<p>Haven Wheelock, a chief petitioner of the measure, is already seeing the impact. As a harm reductionist who administers a syringe service program at OutsideIn in downtown Portland, she is on the frontlines, and has seen the suffering caused by the drug war. It’s one of the main reasons she became so passionate about decriminalization and funding evidence-based treatment.</p>
<p>Her clients, she said, often tell her that they “walk through the world always scared.” The constant fear of arrest for drug possession takes a psychological toll on people who use drugs. Measure 110 has assuaged some of that fear.</p>
<p>“People are finally breathing just a little bit easier.”</p>
<p>A limitation of decriminalization—as opposed to legalization—is that it does not make the drug supply safer. Fentanyl has contaminated a large swath of the market, from heroin and pills purporting to be opioids or benzodiazepines to cocaine and other stimulants. This volatile and unreliable supply, exacerbated by the COVID-19 pandemic, is linked with <a href="https://ajph.aphapublications.org/doi/10.2105/AJPH.2021.306256">unprecedented death rates</a>, even higher than those reported by media.</p>
<p>Wheelock believes Measure 110 brings hope in this regard, however. “One of the benefits &#8230; is we’re going to be able to do effective drug checking and safe consumption spaces within the next three years.”</p>
<blockquote><p>She is working on messaging, so people know just how much of a drug they can possess.</p></blockquote>
<p>Both of these interventions save lives. Safe consumption is currently banned nationwide and drug checking is nearly absent in Oregon. But reforms tend to pave the way for more reforms. And for now, harm reductionists can become involved—in drug checking, for example, which may require taking brief possession of residue amounts of controlled substances—with less fear of legal retribution.</p>
<p>While much confusion around this rapid policy shift remains, Wheelock sees the positives. She is working on messaging, so people know just how much of a drug they can possess before it becomes an arrestable offense. For heroin, it’s one gram—less than many people use in one day or buy at a time. For other substances, the quantities are less strict.</p>
<p>When a law enforcement officer finds someone in possession of drugs, they are now written a Class E violation. They will either face a $100 fine, or undergo an assessment within 45 days. If the assessment is not completed, the fine will be imposed. People caught with drugs who do not have a SUD still must still complete the assessment—but if the assessment tools work as intended they won’t be recommended to treatment. For people diagnosed with SUD and recommended treatment, completing treatment is not mandatory. Once an assessment is completed, the violation is dismissed.</p>
<p>People can alternatively show up to court to contest the ticket and a judge is authorized to reduce the fine to the minimum of $45. If the judge determines the ticket to have been given improperly, it could also be dismissed.</p>
<p>Importantly, unpaid fines will never trigger incarceration and missed court dates will never trigger a warrant for failure to appear. The Oregon Judicial Department is developing an e-filing system with Lines of Life so that when people complete their assessments, that information is automatically given to the courts.</p>
<p>The legislature is in the home stretch of finalizing SB755—the bill to make Measure 110 become law. Dozens of amendments have been compiled from their respective work groups and weaved into one single bill.</p>
<p>Questions not addressed in the text of the ballot measure had to be answered by the legislature—such as which category of court would attend to the newly-created Class E violations (the answer: circuit courts) or which professionals should conduct the screenings (likely to be certified drug and alcohol counselors and peers).</p>
<p>There were some quirky legal issues. For example, the measure only modified Oregon’s pre-existing drug codes, from which fentanyl and hydrocodone were omitted. (Instead they defaulted to the federal Schedule II statute.). But that was perceived as an accidental oversight and “user amounts” for both fentanyl and hydrocodone have now been defined—and therefore decriminalized.</p>
<p>&nbsp;</p>
<h4 style="text-align: center;">The Measure&#8217;s Health Care Arm</h4>
<p>Other questions surround Measure 110’s treatment funding arm. A temporary phone line, administered by the nonprofit Lines for Life, has been set up to provide the assessments and referrals to services demanded by small-scale possession cases in the new era.</p>
<p>The measure emphasizes harm reduction, supportive housing, peers to mitigate retention and navigation barriers, and the full spectrum of treatment services, including medications for opioid use disorder. The funding for all this is not supposed to be restricted to people who receive citations for drug possession—any Oregonian who requests services will be eligible. It is a truly fundamental shift in how the state deals with substance use, recognizing the importance of services for people who actively use drugs as well the importance of being securely housed. Some say there isn’t enough money to meet the need, but it is a start.</p>
<p>Intended as a stop-gap until what the measure called “Addiction Recovery Centers” can be set up statewide, the phone line could yet become a permanent fixture. Like so much else, that remains to be seen.</p>
<p>Oregon’s budget biennium ends on June 30. The cannabis tax revenue earned in the first quarter of 2021, stipulated by Measure 110 to go to the Drug Treatment and Recovery Services Fund, was already slated to go elsewhere.</p>
<p>This conflict between the measure, voter intent and Oregon’s budget cycles has been somewhat mitigated by the legislature: On March 16, the Oregon House of Representatives announced an allocation of $20.2 million for immediate disbursement into the fund—a rare instance of legislators moving faster than expected.</p>
<blockquote><p>The foundational shift can be felt in the council meetings.</p></blockquote>
<p>Implementation of Measure 110’s health care aspects has many more moving parts—not least the Oversight and Accountability Council (OAC), which was mandated to be formed by the date decriminalization took effect. The Oregon Health Authority voluntarily raised the number of council members to 21, above the minimum of 16 set out in the measure.</p>
<p>I was appointed by the Oregon Health Authority to the Council because of my lived experience with repeated incarceration for heroin possession, my less-than-pleasant experiences in drug court, and my current public health expertise and my drug policy research position at the <a href="https://www.healthinjustice.org/">Health in Justice Action Lab</a>.</p>
<p>The foundational shift can be felt in the council meetings. Many of the councilmembers have been directly impacted by incarceration or addiction; others are leaders in the treatment and recovery services field. In a state that is 85 percent white (though Census Bureau race statistics obfuscate Latinx heritage), the majority of members are people of color—a damning recognition of the drug war’s disproportionate impacts.</p>
<p>Black and Indigenous Oregonians are grossly overrepresented in the criminal-legal system and in <a href="https://www.oregonlive.com/politics/2016/12/stark_racial_disparities_emerg.html">drug arrests specifically</a>. Black Oregonians are convicted of drug possession at a rate two-to-three times that of whites, while Indigenous Oregonians are convicted at a rate <a href="https://www.oregon.gov/CJC/SAC/Pages/pcs.aspx">five times higher</a>. Upholding values of racial justice is a defining aim of the landmark bill.</p>
<p>While Measure 110 modified pre-existing segments of the Oregon Revised Statutes around drug possession, it also added entirely new language. Senate Bill 755 is taking all of the pieces and “plugging them in” to state law. This process has been far more arduous than it sounds, requiring three separate Senate work groups involving an extraordinary range of stakeholders and hundreds upon hundreds hours of work.</p>
<p>There have been major changes to the treatment section of the bill, but with near-unanimous support from stakeholders. Language has been one area of heated discussion. The name “Addiction Recovery Center” was deemed problematic because of the implication it must be a “center”—a brick-and-mortar location—which may not be necessary, or even possible, in all areas of the state. While Oregon’s population is heavily concentrated in the Willamette Valley, containing the Portland Metro and Eugene, the vast majority of the state is rural.</p>
<blockquote><p>Drugs are <i>not</i> decriminalized on tribal land, which is subject to federal law.</p></blockquote>
<p>There was also conversation around the term “addiction” since the medical terminology is substance use disorder—and even then, not everyone accessing services will meet the diagnostic criteria. “Behavioral Health Resource Network” is the frontrunner. The term “assessment” has been changed to “screening.” It was mandated in the ballot measure as being performed by a “licensed treatment provider,” meaning Lines for Life could only hire people with CADC certification and not peer mentors—another hiccup that is being rectified by the bill.</p>
<p>Meanwhile, the OAC is busily determining how it will distribute grants from the Drug Treatment and Recovery Fund. It has $20 million to dole out by June 30, and then each quarter thereafter, depending on cannabis tax revenue. Current revenue projections from the Legislative Fiscal Office amount to $318 million for the 2021-23 cycle, of which $228 million would be routed into the fund for disbursement, broken down into eight quarters over the two years.</p>
<p>The Oregon Health Authority is also negotiating with the state’s nine federally recognized tribes to ensure they receive adequate funding. It is important to note that drugs are <i>not</i> decriminalized on tribal land, which is subject to federal law.</p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Some Severe Challenges</h4>
<p>Aaron Knott, policy director at the Multnomah County District Attorney’s Office,  which ceased prosecuting drug possession earlier than the rest of the state at the behest of DA Mike Schmidt, called Measure 110’s timelines “the most aggressive I have ever seen in a ballot measure.”</p>
<p>He has a point. From distributing grant funding to fundamentally altering policing and the courts, things are required to move remarkably fast.</p>
<p>However, despite some pushback from community advocates fearing unnecessary bureaucratic footdragging, the timelines have now been somewhat extended by Senate Bill 846—a companion bill to SB755 that also codified into law, in alignment with Measure 110, the changes to how cannabis tax revenue will be distributed.</p>
<p>The deadline to establish the Addiction Recovery Centers, to use their original name, has been extended three months and is now January 1, 2022. The Oversight and Accountability Council now has until September 1, 2021 to establish its rules—a two-month extension. The temporary phone line will no longer be terminated in October, but will rather be extended into at least next year.</p>
<p>Concerns about the measure go beyond its technical workings and logistics. While law enforcement was predictably against it, opposition also came from more unexpected corners—including the recovery community.</p>
<blockquote><p>&#8220;Nonprofits and other people are all advocating for their own things … There’s redundancy all over the place.”</p></blockquote>
<p>“What we have is a system that is fractured and incomplete,” said Tony Vezina. He’s the executive director of 4th Dimension Recovery Center, a nonprofit youth service with multiple locations in the Portland metro area. A person in long-term recovery and a leader in the recovery community, Vezina advocated against Measure 110, even though he doesn’t disagree with decriminalization in principle. He sees the current system as utterly lacking in cohesion, compounded by inadequate resources.</p>
<p>“It’s also fractured from a governance policy perspective,” he said. “I hate to use the word but there should be some type of authority. No one is steering the ship. The system is just this free-market thing where nonprofits and other people are all advocating for their own things … There’s redundancy all over the place.”</p>
<p>Even Measure 110’s strongest proponents would agree that we need to get organized to implement it well. And a good starting point in determining where the state needs to go would be knowing where it is today. Included in the $20.2 million Oversight and Accountability Council allocation, the legislature earmarked $200,000 to go directly to the Oregon Health Sciences University to complete an inventory—determining just what the state does and does not have in terms of a SUD treatment ecosystem.</p>
<p>That’s something the state’s Alcohol and Drug Policy Commission (on which both Vezina and I serve) has been asking for for at least two years, but it was never funded.</p>
<p>“What Measure 110 did was accelerate the decriminalization part, put some money into the system, but then also exacerbated the disorganization,” said Vezina.</p>
<p><img loading="lazy" decoding="async" class="img-responsive wp-image-11961 aligncenter" src="/wp-content/uploads/2021/04/Screenshot-2021-04-21-at-16.50.55.png" alt="" width="621" height="638" srcset="/wp-content/uploads/2021/04/Screenshot-2021-04-21-at-16.50.55-291x300.png 291w, /wp-content/uploads/2021/04/Screenshot-2021-04-21-at-16.50.55-376x387.png 376w" sizes="auto, (max-width: 621px) 100vw, 621px" /></p>
<p style="text-align: center;"><em>Tony Vezina</em></p>
<p>&nbsp;</p>
<p>He also cited well-founded concerns about the preparedness of our health care system, where providers receive little-to-no training in addiction and are known to stigmatize people who use drugs.</p>
<p>Unlike health care, our criminal justice system has always been active, seeking people out and bringing them in. Vezina hopes that the expansion of Oregon’s treatment ecosystem will include more points-of-engagement, actively connecting with people with services. Passively sitting by and waiting for someone to call a number is not sufficient, he believes.</p>
<p>Even having one number to call is progress from where the state was before. Oregon consistently ranks bottom of the pack for treatment access—though defining “treatment” is tricky, as Senate workgroups can confirm. There is no unified system to triage or direct people who need services—or even to identify who needs them. Parents watching their children struggle with SUD have no idea where to go for help, what to do.</p>
<p>The Lines for Life line may be able to refer someone to services, but inadequate supply of those services can result in long wait lists. There may be nowhere for people to go. Further grant allocations from the OAC should improve this situation in time; some providers envision a number like 211—something easy to remember and centralized.</p>
<p>“If it were me, and I was either mandated to an assessment or desperate for help, or had a kiddo I was desperate to get help for, I would want one phone number,” said Jessica Gregg, chief medical officer at DePaul Treatment Centers. “I would want someone to answer it. I would want, ‘This is the next step … if it doesn’t happen, call me back. Here’s my name.’”</p>
<blockquote><p>A key to improving health outcomes is improving integration within and across the service delivery system.</p></blockquote>
<p>Systems integration will remain a barrier to care. Because the US service provision is dependent on grant-funding to thousands of for-profit and nonprofit organizations—and because of our unfathomably complex insurance structure that excludes millions—the burden of navigating this byzntine system falls onto the patient. With no robust public health infrastructure or centralized provider, we have a hodgepodge where everyone works mostly independently. Not coincidentally, despite <a href="https://stats.oecd.org/Index.aspx?DataSetCode=SHA">spending more</a> on health care <i>per capita</i> than any other rich country, the United States reports alarmingly <a href="https://www.worldometers.info/demographics/life-expectancy/">poor health outcomes</a>.</p>
<p>Privileged people in ideal circumstances are often incapable of navigating our systems. For marginalized people who use drugs, with numerous other barriers, it becomes an impossibility.</p>
<p>Dane Zahner, the prevention and harm reduction manager for HIV Alliance, highlighted the myriad obstacles facing the people he serves. “About 50 to 60 percent are homeless,” he said. “They also have transportation needs here in rural Oregon. There are barriers to food and barriers to housing.” The list goes on.</p>
<p>People who are handed a list of phone numbers and sent back to the streets inevitably fall through the cracks. So a key to improving health outcomes is improving integration within and across the service delivery system. Oregon is not Portugal, that famous international example of successful decriminalization coupled with service provisions. The state does have expanded Medicaid, but only 23 percent of the state’s residents are on it. Most of the rest are divided between any number of private insurers. <a href="https://www.oregon.gov/oha/ERD/Pages/NewReportManyOregoniansWhoLackHealthCoverageEligibleForSubsidiesOregonHealthPlan.aspx#:~:text=There%20are%20currently%20about%20243%2C000%20uninsured%20people%20in%20Oregon.">Almost 250,000</a> are uninsured.</p>
<p>To Gregg, one way to help people navigate these labyrinthine systems is simple: “Peers, peers, peers.”</p>
<p>Measure 110 and SB755 repeatedly emphasize the importance of peers, echoing decades of <a href="https://link.springer.com/content/pdf/10.1007/s11606-019-05311-0.pdf">evidence</a> that shows how they increase engagement and retention in SUD treatment. Hopefully the infusion of funds into the system will enable more peer hires—though there are whispers of a looming behavioral health shortage due to low wages, a situation that could, in theory, be mitigated by the extra funds.</p>
<p>COVID has disrupted service provision and fueled surges in both drug use and overdoses. Extricating COVID—the confounding factor—from the data around decriminalization and treatment will be a challenge for researchers studying the outcomes of Measure 110 in years to come. We know that 2020, before decriminalization, was the worst year in history for overdose deaths. 2021 is currently on a similar trajectory.</p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Problems With Policing, High Hopes</h4>
<p>A mere fraction of the people cited for drug possession since February 1 have called Lines for Life, the only currently authorized provider of screenings to avoid that ticket. Some advocates have suggested that law enforcement officers hostile to decriminalization are not communicating the procedure clearly to people cited, or failing to provide the phone number to Lines for Life. They also suggest that people are simply so afraid of police that they are choosing not to engage with the system.</p>
<p>Oregon first fundamentally changed drug policing in 2017, when the legislature reduced possession from a felony to a misdemeanor. Arrests plummeted afterwards, despite drug use likely remaining constant. Whether police changed their tactics or simply didn’t want to bother with a misdemeanor is unknown.</p>
<p>Measure 110 is an even bigger shift. Columbia County Sheriff Brian Pixley recognizes that it will reduce barriers for some people struggling with addiction and could increase the likelihood that someone seeks help, without fear of going to jail. He noted that drugs are not legalized, and will still be confiscated by law enforcement as evidence for what’s now a Class E violation.</p>
<p>He nonetheless has strong reservations about the measure. “Frontline deputies are having to shift their mindset and rethink things like search and seizure, subject stops, detention, and DUIs,” he said.</p>
<p>Some would argue that is the point. The War on Drugs has been used to dramatically expand police powers when it comes to search, seizure and detention, greatly diminishing Fourth Amendment rights. Police interactions, which Measure 110 is intended to reduce, also carry far greater risks for people of color. Portland, for example, has the <a href="https://www.opb.org/article/2021/02/07/portland-has-5th-worst-arrest-disparities-in-the-nation-according-to-data/">fifth worst arrest disparities in the nation</a>, with Black people being killed by police at a rate 3.9 times that of white people.</p>
<blockquote><p>The reality is that the burden of substance use disorder and mental health “care” has largely fallen onto the criminal justice system.</p></blockquote>
<p>Sheriff Pixley also expressed concerns that there will be an increase in crime rates, addiction, and overdose if people no longer fear jail or severe legal repercussions. What evidence we have points the opposite way, however. Oregon, again, is not Portugal. But Portugal <a href="/portugal-decriminalization-drug-use-explained/">saw better outcomes</a> across the board after implementing its own decriminalization model back in 2001.</p>
<p>Pixley hopes to be able to get the funding to provide medications for opioid use disorder in jail and naloxone to people upon their release—funding that could potentially come from the cannabis tax revenue.</p>
<p>The reality of the last several decades is that the burden of substance use disorder and mental health “care” has largely fallen onto the criminal justice system, which—besides the inherent ethical problems—is unequipped and unwilling to handle it. No government alternative was provided.</p>
<p>Tera Hurst is familiar with this reality. She’s the executive director of the Health Justice Recovery Alliance (HJRA), described as the implementation arm of what was the Yes on 110 campaign. Initially supported by the Drug Policy Alliance, HJRA’s fiscal sponsor is now Partnership for Safety and Justice, an Oregon reform organization. They are advocating for funding from the legislature, suitable amendments in SB755, consistent support of the OAC, and overall excellence in implementation.</p>
<p>“Most law enforcement, they have just never had a system that isn’t starved,” Hurst said. “They’ve always had to constantly arrest folks. They watch them cycle through, they watch them on waiting lists. I believe that once we get a funded system where they could actually send somebody and know that’s going to be an avenue and not just a phone number and then they’re back on the street … Once law enforcement sees that commitment, and as long as we continue to get these things funded and up and running, they’re going to be relieved. They will be able to say ‘Hey, call this number. It worked for so-and-so. It works.’”</p>
<p>Seeing, as they say, will be believing. Though some people with SUD who come in contact with the criminal justice system and its programs do find recovery that way, most arrests are destabilizing at best and often traumatizing—or ultimately, deadly. One study showed the risk of overdose being <a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2628297">129 times greater</a> in the two weeks after release from incarceration.</p>
<p>Reducing arrests will mean that fewer people who use drugs will be saddled with criminal records. The collateral, lifelong consequences of criminal convictions are numerous, ranging from housing, to employment, to government benefits, to professional licensure, to immigration.</p>
<p>Jack, a Chinese American man who asked that only his first name be used, got a possession conviction before the 2017 defelonization.</p>
<p>“Being labeled a felon,” he said, “I sometimes feel like a second-class citizen.”</p>
<p>A recognized shortcoming of many decriminalization measures—and of Measure 110 in particular—is the failure to expunge past convictions for things that are no longer criminalized. Jack still has a felony.</p>
<blockquote><p>Jack, who unequivocally supported Measure 110, reflected on how different his life might be had it been in effect before his conviction.</p></blockquote>
<p>Senate Bill 397, currently before congress, makes expungement more accessible by eliminating fees and shortening wait times. But advocates like Tera Hurst and Haven Wheelock want to see it become automatic and sweeping. That is proving to be a heavier bureaucratic lift than it would seem (many records are not digitized), but the wheels are turning for future legislative sessions.</p>
<p>There is also ongoing conversation between lawmakers and immigration experts about how to avoid triggering future deportations—and whether there is any potential for relief for people already removed from the country. (Though that looks bleak.)</p>
<p>Jack, who unequivocally supported Measure 110, reflected on how different his life might be had it been in effect before his conviction—now a common refrain of impacted Oregonians.</p>
<p>“Maybe there would&#8217;ve been better resources to guide me to the right treatment center instead of me hopping around, for years on end, in and out of different treatment centers before I found a program that worked for me,” he said. “Possibly could&#8217;ve saved years of my life I can never get back.”</p>
<p>“Punitive measures aren&#8217;t effective in addressing this issue,” he continued. “Jail does nothing but worsen the problem… I didn&#8217;t learn anything of any value during my tenures in jail. I learned nothing but to perfect the crimes I already did and I learned more crimes to feed my addiction.”</p>
<p>As of February 1, the state of Oregon stopped inflicting some of its worst harms on people who use drugs. Now comes the healing phase—if it is handled right.</p>
<p>There are many moving parts, and in the short-term, there will be hard work and growing pains. In the long-term, experts are hopeful. People who use drugs are already breathing a sigh of relief. But it remains to be seen whether Measure 110 turns out to be the domino that brings the entire drug war crashing down.</p>
<hr />
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><em>Top photograph courtesy of the Yes on 110 campaign. Other photographs courtesy of Tanesia DeMacon and Tony Vezina.</em></p>
<p><i><a href="https://www.rstreet.org/" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://www.rstreet.org/&source=gmail&ust=1619120749732000&usg=AFQjCNGTF09rnpQ48SB5ipUOVtE4MtofwQ">R Street Institute</a> supported the production of this piece through a restricted grant to The Influence Foundation, which operates </i>Filter<i>.</i></p>
<p><em>The Drug Policy Alliance previously provided a restricted grant to The Influence Foundation to support a Drug War Journalism Diversity Fellowship.</em></p>
<p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=%2Fdrug-decriminalization-oregon%2F&linkname=Drug%20Decriminalization%20in%20Oregon%3A%20How%E2%80%99s%20It%20Going%20So%20Far%3F" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=%2Fdrug-decriminalization-oregon%2F&linkname=Drug%20Decriminalization%20in%20Oregon%3A%20How%E2%80%99s%20It%20Going%20So%20Far%3F" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_email" href="https://www.addtoany.com/add_to/email?linkurl=%2Fdrug-decriminalization-oregon%2F&linkname=Drug%20Decriminalization%20in%20Oregon%3A%20How%E2%80%99s%20It%20Going%20So%20Far%3F" title="Email" rel="nofollow noopener" target="_blank"></a></p><p>The post <a href="/drug-decriminalization-oregon/">Drug Decriminalization in Oregon: How&#8217;s It Going So Far?</a> appeared first on <a href="/">Filter</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>I Hid My Wounds for Months and Nearly Lost My Life: Stigma Kills Drug Users</title>
		<link>/hospital-drug-wounds-stigma/</link>
		
		<dc:creator><![CDATA[Louise Vincent]]></dc:creator>
		<pubDate>Tue, 30 Mar 2021 10:00:27 +0000</pubDate>
				<category><![CDATA[FilterMag]]></category>
		<category><![CDATA[Intersections + Injustice]]></category>
		<category><![CDATA[healthcare]]></category>
		<guid isPermaLink="false">/?p=11811</guid>

					<description><![CDATA[<p>It could almost have been a Saturday Night Live skit. I wish to God it was. Someone came into my ...</p>
<p>The post <a href="/hospital-drug-wounds-stigma/">I Hid My Wounds for Months and Nearly Lost My Life: Stigma Kills Drug Users</a> appeared first on <a href="/">Filter</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span class="wpsdc-drop-cap">I</span>t could almost have been a <i>Saturday Night Live</i> skit. I wish to God it was. Someone came into my hospital room wearing a yellow suit straight out of Star Trek. Doctors then arrived to add what to me was just technobabble. <em>Well</em>, they said, <em>you have Methicillin-resistant Staphylococcus aureus</em> (MRSA). <em>And hepatitis C</em>.</p>
<p>I can laugh a little about it now, but it still makes my blood boil. How many more of us have to die? Just how fucking <em>many</em>? All because almost no one cares about people who use drugs.</p>
<p>It was back in 2004 when I had that terrifying experience. I was fairly new at drug injection, and had no access to sterile supplies or reliable information. Older drug users and their knowledge were my only hope for staying safe.</p>
<p>I started to run fevers, and to develop abscesses on my body that weren’t connected to any injury or injection site. One evening, I found the courage to walk into a local pharmacy and ask the pharmacist what happens if your blood becomes infected. He answered very matter-of-factly.</p>
<p>“You die, dear. You die.”</p>
<p>In the hospital, I had no idea what the diagnoses they had given me meant, neither the MRSA part—referring to a group of bacteria that cause hard-to-treat staph infections—nor hepatitis C.</p>
<p>But I learned many lessons. One was that we need to inform ourselves when nobody else takes the trouble. Hospital policy and our medical system create deadly barriers for people who use drugs. We are then not able to access the help we need and are left to deal with life-threatening infections by ourselves. When they have security searches and room sitters, leave us in pain and withdrawal and refuse to allow any guests for us, we leave against medical advice.</p>
<blockquote><p>Here I am again. Here is the truth, after seven or eight months of shame and secrecy.</p></blockquote>
<p>My developing these infections had really been a toss-up, it turned out. People who inject drugs are at their <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722077/">most vulnerable</a> to hep C transmission in their first two years of injecting. I would hypothesize that this vulnerability has only increased at a time when more people, in my experience, now begin their drug use injecting, rather than coming to it via snorting or smoking.</p>
<p>I hoped I would never have another experience like that, but that is not my reality.</p>
<p>Here I am again. Here is the truth, after seven or eight months of shame and secrecy. Throughout that time, I have been hiding wounds and abscesses. Terrified, I have taken different assortments of antibiotics from Canada, and watched myself get closer to death day by day.</p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Medical PTSD and a Life-Threatening Emergency</h4>
<p>For a few years before the pandemic, I traveled as part of my job. Every other week, I was in a new city. I was on methadone, but the clinic and its requirement of regular attendance, together with all the hassle of guest-dosing while I was away, made this all but impossible.</p>
<p>If you’ve ever been forced to participate in methadone guest-dosing, you’ll know that it’s expensive as shit, and they do all they can to make it inconvenient and inaccessible. So instead, I would often just get whatever I needed to be well in whatever city I happened to be in. It wasn’t exactly what I wanted, but this was the only way to travel without the insanity of the methadone clinic.</p>
<blockquote><p>They told me that I had failed at the treatment they’d offered.</p></blockquote>
<p>That’s why I tried to move from my methadone clinic to a buprenorphine doctor. It would allow me to travel without dealing with the restrictions of the clinic. I tried to make the switch, but it was a total disaster. I wound up being thrown out of the clinic for missing days due to travel and drug use. I tortured myself trying to transition, but ultimately couldn’t do it.</p>
<p>With my head down, I called my methadone clinic and asked to come back. They were less than kind; instead of welcoming me back and helping me, they told me that I had misused the clinic and had failed at the treatment they’d offered.</p>
<p>Despite everything, I still could not believe they would deny me all services. How could they treat me this way? I had been a client of that clinic for over 10 years, paying upward of $14 a day. When I think of the money alone that I must have brought them during that time, surely that gave them some incentive to treat me with dignity and decency? They branded me a failure instead.</p>
<p>The truth is, for all my struggles, I did <i>well </i>during my years at this clinic. I graduated college and grad school. I lost my daughter to an OD and had my leg amputated, and I kept going. I became the executive director of <a href="https://ncurbansurvivorunion.org/about/who-we-are/">Urban Survivors Union</a> and a national leader in harm reduction. But to this program I was a failure.</p>
<p>I began to look for another clinic that would take me. But this was hugely problematic. My benzo use was a problem, then my Ambien use; places wouldn’t take me unless I quit those drugs first. I have been on benzos and Ambien since I was 16—including the entire decade I have been on methadone—but they didn’t care. They would not move my dose of methadone up past 40 mg, which wasn’t enough.</p>
<blockquote><p>I ended up traveling one hour each-way every day to get an inadequate methadone dose.</p></blockquote>
<p>The one clinic I eventually found that would take me was miles away. So I ended up traveling one hour each way every day to get an inadequate methadone dose—they would not move my dose up past 40 mg—all when I had a clinic five minutes from my house that wouldn’t allow me to return.</p>
<p>After eight months of this, my frustration reached an all-time high. I was using, because the methadone dose wasn’t enough to hold me.</p>
<p>Ever since right after the pandemic started and our drug supply went wacky, the dope I was doing had been strange and getting stranger. At Urban Survivors Union, we were donated the money to buy a  mass spectrometer. This is how we discovered the horse tranquilizer <a href="/tranq-dope-the-heroin-combo-thats-been-putting-philly-to-sleep/">xylazine</a> in the drugs I was using. Without the mass spectrometer to indicate what was behind the most frightening injection wounds you could imagine, I would have surely died.</p>
<p>But I was too traumatized to seek help from the doctor. My 2004 hospital trip was only one of many scarring experiences. I am disabled and have vision in only one eye. I spent years being mistreated and harmed after being hit by a car and losing my leg in 2014. My PTSD is real.</p>
<p>So what did I do? I began treating myself with antibiotics I was able to procure, and made very clear to my loved ones not to <i>ever</i> try to make me go to the hospital. And my health got worse and worse. As my friends urged me to go to the doctor, I tried to think about all the reasons I want to live. I tried to be brave and strong. But all it amounted to was me curled up in a ball, trying to breathe.</p>
<blockquote><p>I had lost all the weight I could lose. I was pale as a ghost, exhausted and struggling to breathe. My hair was falling out.</p></blockquote>
<p>My injection wounds were just one of many side effects as my body was slowly poisoned. I was scared, for me and for everyone else who might be injecting this poison thinking it was dope.</p>
<p>I had lost all the weight I could lose. I was pale as a ghost, exhausted and struggling to breathe. My hair was falling out. I was trying to cope with this while getting off of benzos and Ambien as fast as possible.</p>
<p>I finally decided that the shame and secrecy had to stop. I reached out to my colleague who is an epidemiologist.</p>
<p>My colleague convinced me that I needed to seek medical help for my wounds and met me at a sympathetic wound care doctor. Turns out, I had a 2.9 hemoglobin, was having a medical emergency and needed to go to the emergency room.</p>
<p>This is when I fell apart. I could not stand a hospital, the treatment. I could not face the hateful people I would be forced to deal with. I could not deal with the withdrawal I would most certainly face if I went. I said I would rather die, and I meant it. But Don, my partner, took me to the hospital. As he drove me down I-40, I was on the floor of the car, hyperventilating and hysterically crying, “I can’t do this!”</p>
<blockquote><p>Like every other experience of this kind, it will deter me from seeking help again.</p></blockquote>
<p>My colleagues worked on making a plan so we could better ensure that I would avoid emotional abuse at the hospital. They did everything they could. I had health advocates with me; my colleagues themselves came to offer support.</p>
<p>I am here to report that while all of this made it possible for me to get a blood transfusion and get some help, this trip to the ER was just as painful and traumatizing as many of my other experiences. We face policies designed to violate our basic human rights, and we face stigma: We are treated as if we did this to ourselves and deserve our condition. On top of being scared and in full withdrawal, this was another experience with hateful nurses and indignant doctors, with a complete inability to listen to a patient and respond to basic needs. Like every other experience of this kind, it will deter me from seeking help again.</p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Not Your Mama&#8217;s Heroin</h4>
<p>Drug use is simply different than it once was. As my good friend always says, “This ain’t your mama&#8217;s heroin!” I feel like I need to scream this from the rooftops. So many of our policies, bad enough in their own right, are connected to drugs and situations that are no longer relevant.</p>
<p>So many health care providers still operate as if we are dealing with heroin, <a href="/last-days-heroin-fentanyl/">which we are <i>not</i></a>. We are dealing with fentanyl and tranquilizers and never-before-seen cutting agents. We are dealing with street prices during the pandemic that double and triple and prompt desperation. Rather than getting clients on stable methadone doses as an urgent priority, clinics continue to throw up barriers. Our access to anything that looks remotely like safe supply is nonexistent.</p>
<p>The drug-user health clinic that I run in North Carolina has been seeing skin and soft tissue infections unlike any we have known before. People identify cuts and wounds that “just appeared” from nowhere, just like my own.</p>
<p>We use fentanyl test strips, but these unsophisticated tools aren’t enough when there are so many substances in the mix. Drug-checking resources must be upgraded everywhere.</p>
<blockquote><p>Regulators look for things they can count before they issue help. I suggest they count the bodies lining up at their feet.</p></blockquote>
<p>Urban Survivors Union has been working with methadone state regulators around the country, trying to make changes to methadone policies while the country is closed. We are fighting in hopes to reopen the country with policies that actually have the ability to save lives.  We must deal with our broken medical system that condemns people who use drugs and violates our human rights with little to no thought.</p>
<p>We speak to the regulators and they say they are sympathetic, but it does not seem as if they are able to make any real change. Regulators look for things they can count before they will issue help. Well, I suggest they count the dead bodies lining up at their feet.</p>
<p>Drug-testing equipment saved my life. We have a treacherous drug supply with deadly poison mixed in. I am the leader of a drug-user union. If <i>I</i> can die from our poisoned drug supply, so can anyone. We must act now to get the safe supply and resources that we need. We must not be silent, ashamed or scared. We must talk, even if we are hated. We must scream, if that is what it takes.</p>
<p>Please fight with us. Stand with us. Help us in ways that are useful. Listen to people who use drugs and develop policies that place our health first. We cannot afford anything else.</p>
<p>&nbsp;</p>
<hr />
<p>&nbsp;</p>
<p><em>Thank God for Nan Goldin, the artist and advocate <a href="https://fadmagazine.com/2020/04/24/nan-goldin-limited-edition-to-benefit-urban-survivors-union/">whose project funded</a> Urban Survivors Union&#8217;s purchase of the mass spectrometer. Her swift action in response to the pandemic emergency saved not only my life but many others. Thank you, Nan. You are a true hero of mine. Thank you to everyone at USU, the USU methadone team, to my friends who are scientists, to Nab and Roxanne, to my friends Erica and Allison who cared for me when I was at my worst, and to my lover and friend Don. You kept me alive day by day. I love you all.</em></p>
<p><em><a href="https://www.canva.com/design/DAEXoegEiW8/eE6cCcUFiUzoJW0riVuNZA/watch?utm_content=DAEXoegEiW8&utm_campaign=designshare&utm_medium=link&utm_source=sharebutton">Here is a video</a>, created and developed by USU and produced by Knina Strichartz, to thank Nan from all of us.</em></p>
<p><em>Photo by <a href="https://unsplash.com/@jkeeeeyy?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Jake Espedido</a> on <a href="https://unsplash.com/s/photos/emergency?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Unsplash</a> </em></p>
<p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=%2Fhospital-drug-wounds-stigma%2F&linkname=I%20Hid%20My%20Wounds%20for%20Months%20and%20Nearly%20Lost%20My%20Life%3A%20Stigma%20Kills%20Drug%20Users" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=%2Fhospital-drug-wounds-stigma%2F&linkname=I%20Hid%20My%20Wounds%20for%20Months%20and%20Nearly%20Lost%20My%20Life%3A%20Stigma%20Kills%20Drug%20Users" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_email" href="https://www.addtoany.com/add_to/email?linkurl=%2Fhospital-drug-wounds-stigma%2F&linkname=I%20Hid%20My%20Wounds%20for%20Months%20and%20Nearly%20Lost%20My%20Life%3A%20Stigma%20Kills%20Drug%20Users" title="Email" rel="nofollow noopener" target="_blank"></a></p><p>The post <a href="/hospital-drug-wounds-stigma/">I Hid My Wounds for Months and Nearly Lost My Life: Stigma Kills Drug Users</a> appeared first on <a href="/">Filter</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Illinois Methadone Patients Could Be First to Have Privacy Rolled Back After SAMHSA Rule-Change</title>
		<link>/illinois-methadone-privacy-samhsa/</link>
		
		<dc:creator><![CDATA[Sessi Kuwabara Blanchard]]></dc:creator>
		<pubDate>Mon, 29 Mar 2021 11:56:52 +0000</pubDate>
				<category><![CDATA[FilterMag]]></category>
		<category><![CDATA[Intersections + Injustice]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[MAT]]></category>
		<category><![CDATA[opioids]]></category>
		<guid isPermaLink="false">/?p=11808</guid>

					<description><![CDATA[<p>An Illinois Senator appears to be the first state lawmaker to push for a bill that would make a controversial ...</p>
<p>The post <a href="/illinois-methadone-privacy-samhsa/">Illinois Methadone Patients Could Be First to Have Privacy Rolled Back After SAMHSA Rule-Change</a> appeared first on <a href="/">Filter</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span class="wpsdc-drop-cap">A</span>n Illinois Senator appears to be the first state lawmaker to push for a bill that would make a controversial federal rollback of opioid use disorder patients’ privacy rights mandatory at the state level.</p>
<p><span style="font-weight: 400;">On February 26, state Senator Mattie Hunter introduced Senate Bill (SB) 1844 to require so-called opioid treatment programs (OTP), often known as methadone clinics, to share the data of consenting patients with the Illinois Prescription Monitoring Program (IPMP).</span></p>
<p><span style="font-weight: 400;">The bill comes after a successful effort by the Substance Abuse and Mental Health Services Administration (SAMHSA), the federal agency regulating OTPs, to change the regulation, codified in 42 CFR Part 2, that has historically protected OTP patients’ privacy. SAMHSA had already been </span><a href="/confidentiality-for-patients-with-substance-use-disorders-is-under-threat/"><span style="font-weight: 400;">tweaking</span></a><span style="font-weight: 400;"> the protections, but a more radical shift in policy </span><a href="/samhsa-patient-privacy/"><span style="font-weight: 400;">came in July 2020</span></a><span style="font-weight: 400;">, when it finalized a rule-change permitting OTPs to disclose patient information to </span><a href="/how-helpful-or-harmful-are-prescription-drug-monitoring-programs/"><span style="font-weight: 400;">prescription drug monitoring programs</span></a><span style="font-weight: 400;"> (PDMP). That’s in contrast to a </span><a href="https://www.samhsa.gov/sites/default/files/programs_campaigns/medication_assisted/dear_colleague_letters/2011-colleague-letter-state-prescription-drug-monitoring-programs.pdf"><span style="font-weight: 400;">2011 “Dear Colleague” letter</span></a><span style="font-weight: 400;"> by the agency’s </span><span style="font-weight: 400;">Center for Substance Abuse Treatment </span><span style="font-weight: 400;">warning against it.</span></p>
<p><span style="font-weight: 400;">On its face, the proposed Illinois law seems to be protecting patients’ privacy. It requires consent before sharing the data, and it specifically bans conditioning the provision of treatment on consent—which attorneys Jacqueline Seitz and Deborah Reid of Legal Action Center, a legal advocacy organization that specializes in substance use disorder treatment law, said is “a significant protection for patients, and we would like to see similar prohibitions in all state laws.” It also prohibits sharing the patient’s signed consent document with law enforcement.</span></p>
<p><span style="font-weight: 400;">But both matters are complicated.</span></p>
<p><span style="font-weight: 400;">Some advocates have been worried that OTP patients may not be fully informed of the implications of consenting to PDMP disclosures. In a </span><a href="http://www.aatod.org/advocacy/policy-statements/aatod-pdmp-policy-guidance-statement-for-otps/?utm_source=Amendment+to+Confidentiality&utm_campaign=medicaid+webinar+6&utm_medium=email"><span style="font-weight: 400;">guidance statement </span></a><span style="font-weight: 400;">just before SAMHSA’s finalized rule, the American Association for the Treatment of Opioid Dependence (AATOD) stressed that patients ought to be informed that their private health data “cannot be taken back” once shared with a PDMP.</span></p>
<p><span style="font-weight: 400;">Agreeing that it’s “not a perfect guarantee of patients&#8217; privacy rights and right to access confidential treatment,” Seitz and Reid raised the question, “how will patients know that they have the right not to authorize disclosure to the PDMP?” They added: &#8220;Many of us have been in doctor&#8217;s offices and had a pile of paperwork pushed in front of us to sign, without knowing whether or not signing the paperwork is a condition of treatment.”</span></p>
<p><span style="font-weight: 400;">Law enforcement’s access to IPMP appears to be staunchly limited by the plain language of SB 1844. But recent changes in federal regulation have created </span><a href="/samhsa-law-enforcement-mat/"><span style="font-weight: 400;">more openings</span></a><span style="font-weight: 400;"> for patient information to be unlocked for criminal investigations. In December 2020, SAMHSA </span><a href="https://www.federalregister.gov/documents/2020/12/14/2020-25810/confidentiality-of-substance-use-disorder-patient-records"><span style="font-weight: 400;">finalized</span></a><span style="font-weight: 400;"> a rule that allows law enforcement to seek access to PDMP records for an OTP patient in a criminal investigation or prosecution, even if that individual was not the one to have “allegedly committed” the “seriously extreme crime,” which the agency clarified includes drug trafficking.</span></p>
<p><span style="font-weight: 400;">Again, Seitz and Reid see the bill as raises more questions than answers. “</span><span style="font-weight: 400;">How will PDMPs meaningfully prevent law enforcement from using Part 2 data to criminally investigate or prosecute a patient, as required by Part 2? How will a patient enforce their right to revoke their consent? And how will a patient know if the PDMP illegally re-discloses their treatment records?” they questioned.</span></p>
<p><span style="font-weight: 400;">The stakes of the bill are also unequally distributed by race. “Facilitating law enforcement access to treatment records disproportionately harms BIPOC communities, which are already overpoliced and underserved, and reflects an outdated and unproven strategy for addressing substance use disorders and fatal overdoses,” Seitz and Reid said. “Patients deserve confidential healthcare treatment for their substance use disorders, which should be treated as a health condition—not a crime.”</span></p>
<p><span style="font-weight: 400;">Senator Hunter did not respond to </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">’s request for comment about her legislation. She has a professional history with substance use disorder treatment. She is a Certified Alcohol and Drug Counselor, which she says, according to her website, “has equipped” her with “</span><span style="font-weight: 400;">expertise in crafting substance abuse and addiction prevention policies.”</span></p>
<p><span style="font-weight: 400;">The Illinois legislation has been referred to the Senate’s Assignments Committee, where it awaits its next step in the legislative process. At publication time, SB 1844 does not appear to be scheduled for review by any committee.</span></p>
<p><span style="font-weight: 400;">Despite the potential lack of momentum behind the bill, Senator Hunter’s introduction of SB 1844 confirms the prediction of AATOD, that OTP information sharing with PDMPs would “</span><span style="font-weight: 400;">become a state-by-state issue.”</span></p>
<p><span style="font-weight: 400;">“The August 2020 rule change left a lot of ambiguity for patients, providers and PDMPs,” said Seitz and Reid, “and we are just beginning to see how states and PDMPs attempt to implement the change.”</span></p>
<hr />
<p>&nbsp;</p>
<p><em>Photo by <a href="https://unsplash.com/@ikukevk?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Kevin Ku</a> on <a href="https://unsplash.com/collections/3610398/database-?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Unsplash</a> </em></p>
<p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=%2Fillinois-methadone-privacy-samhsa%2F&linkname=Illinois%20Methadone%20Patients%20Could%20Be%20First%20to%20Have%20Privacy%20Rolled%20Back%20After%20SAMHSA%20Rule-Change" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=%2Fillinois-methadone-privacy-samhsa%2F&linkname=Illinois%20Methadone%20Patients%20Could%20Be%20First%20to%20Have%20Privacy%20Rolled%20Back%20After%20SAMHSA%20Rule-Change" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_email" href="https://www.addtoany.com/add_to/email?linkurl=%2Fillinois-methadone-privacy-samhsa%2F&linkname=Illinois%20Methadone%20Patients%20Could%20Be%20First%20to%20Have%20Privacy%20Rolled%20Back%20After%20SAMHSA%20Rule-Change" title="Email" rel="nofollow noopener" target="_blank"></a></p><p>The post <a href="/illinois-methadone-privacy-samhsa/">Illinois Methadone Patients Could Be First to Have Privacy Rolled Back After SAMHSA Rule-Change</a> appeared first on <a href="/">Filter</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Extending Telehealth Bupe Past the Pandemic Wouldn’t Require Congress</title>
		<link>/telehealth-buprenorphine-samhsa-dea/</link>
		
		<dc:creator><![CDATA[Brandon A. Dorfman]]></dc:creator>
		<pubDate>Mon, 22 Mar 2021 13:13:05 +0000</pubDate>
				<category><![CDATA[FilterMag]]></category>
		<category><![CDATA[Intersections + Injustice]]></category>
		<category><![CDATA[buprenorphine]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[MAT]]></category>
		<guid isPermaLink="false">/?p=11744</guid>

					<description><![CDATA[<p>Before our telehealth appointment ended one day last summer, my buprenorphine doctor asked me if going for monthly urine screens ...</p>
<p>The post <a href="/telehealth-buprenorphine-samhsa-dea/">Extending Telehealth Bupe Past the Pandemic Wouldn’t Require Congress</a> appeared first on <a href="/">Filter</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span class="wpsdc-drop-cap">B</span>efore our telehealth appointment ended one day last summer, my buprenorphine doctor asked me if going for <a href="/urine-screen-drug-treatment/"><span style="font-weight: 400;">monthly urine screens</span></a><span style="font-weight: 400;"> during a pandemic was challenging, and I stumbled over my words.</span></p>
<p><span style="font-weight: 400;">After that first troubling month of lockdown in the spring, my provider had switched to a low-barrier telemedicine model for the duration of COVID-19 out of concern for patient safety. </span><a href="https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-022)(DEA068)%20DEA%20SAMHSA%20buprenorphine%20telemedicine%20%20(Final)%20+Esign.pdf"><span style="font-weight: 400;">Temporary regulations</span></a><span style="font-weight: 400;"> instituted by the Drug Enforcement Administration and Substance Abuse and Mental Health Services Administration allowed this.</span></p>
<p><span style="font-weight: 400;">We now conduct our business </span><span style="font-weight: 400;">once a month</span> <span style="font-weight: 400;">over the phone in under five minutes with a series of simple, rapid-fire questions. The doctor asks me how I’m doing, if I have any cravings, and if I’m happy with my dose. “Thank you for getting your urine sample done,” is how</span> <span style="font-weight: 400;">he ends every call.</span></p>
<blockquote><p><span style="font-weight: 400;">In the middle of a pandemic, I sit in a room where people draw blood and hand over bodily fluids to prove I’m not using drugs.</span></p></blockquote>
<p><span style="font-weight: 400;">I also make regular trips to LabCorp, located in a nearby Walgreens, for the required urine screens.</span></p>
<p><span style="font-weight: 400;">Each month I put on a mask—</span><a href="https://www.cdc.gov/mmwr/volumes/70/wr/mm7007e1.htm"><span style="font-weight: 400;">sometimes two</span></a><span style="font-weight: 400;">—and head out to my appointment, regardless of stay-at-home orders, infection rates and vaccine availability. In the middle of a pandemic, I sit in a room where people draw blood and hand over bodily fluids to prove I’m not using drugs. I do this to continue receiving lifesaving medication. I do this because of the stigma against people who use drugs.</span></p>
<p><span style="font-weight: 400;">The federal government’s telemedicine policies for buprenorphine patients, though temporary, are a</span> <span style="font-weight: 400;">rare bright spot in a catastrophic</span> <span style="font-weight: 400;">year for public health. But </span><a href="/telehealth-services-moud-access/"><span style="font-weight: 400;">beneficial as these models are</span></a><span style="font-weight: 400;"> in bringing low-barrier treatment to underrepresented populations, stigma still prevents permanent</span> <span style="font-weight: 400;">implementation.</span></p>
<p><span style="font-weight: 400;">As the Pew Charitable Trusts </span><a href="https://www.pewtrusts.org/en/research-and-analysis/articles/2021/02/23/federal-agencies-should-extend-pandemic-flexibilities-for-treating-opioid-use-disorder"><span style="font-weight: 400;">noted</span></a><span style="font-weight: 400;"> recently, physicians and public health experts worry that access to treatment could become a problem when the COVID-19 public health emergency ends, as it’s set to do in April. Some groups, such as the Buprenorphine Telehealth Consortium </span>understandably <a href="https://www.healthaffairs.org/do/10.1377/hblog20200910.498716/full/"><span style="font-weight: 400;">argue</span></a><span style="font-weight: 400;"> that an act of Congress </span>is desirable <span style="font-weight: 400;">to extend or make permanent telehealth flexibilities for buprenorphine patients. But could there be a faster immediate way of getting this done?</span></p>
<p>&nbsp;</p>
<h4 style="text-align: center;">SAMHSA and the DEA Could Do It on Their Own</h4>
<p><span style="font-weight: 400;">A </span><a href="https://regulatorystudies.columbian.gwu.edu/telemedicine-initiating-buprenorphine-treatment"><span style="font-weight: 400;">new report from George Washington University</span></a><span style="font-weight: 400;">, funded by </span><span style="font-weight: 400;">Pew</span><span style="font-weight: 400;">, contends that the DEA and SAMHSA have the power to</span> <span style="font-weight: 400;">act unilaterally to extend the nation’s telehealth policies for buprenorphine patients</span><b>.</b></p>
<p><span style="font-weight: 400;">Beth Connolly, who directs the </span><a href="https://www.pewtrusts.org/en/projects/substance-use-prevention-and-treatment-initiative"><span style="font-weight: 400;">Substance Use Prevention and Treatment Initiative at Pew</span></a><span style="font-weight: 400;">, noted that</span> <span style="font-weight: 400;">federal agencies under the Trump administration implemented telemedicine policies rather quickly in the early days of COVID-19. But Pew wanted to know if the temporary regulations in place could be extended without congressional intervention.</span></p>
<p><span style="font-weight: 400;">The organization partnered with George Washington University and asked researchers to look at a slew of regulations, including the Controlled Substances Act, the Ryan Haight Online Pharmacy Consumer Protection Act, and others, to see if outside agencies had any say in the matter.</span></p>
<blockquote><p><span style="font-weight: 400;">They found that the DEA and SAMHSA have not one, but</span><i><span style="font-weight: 400;"> several</span></i><span style="font-weight: 400;"> different ways in which they can extend current telehealth policies.</span></p></blockquote>
<p><span style="font-weight: 400;">“In fact, [researchers] have determined that they can be done without an act of Congress, which is huge.” Connelly told </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;">.</span></p>
<p><span style="font-weight: 400;">Bridget Dooling and Laura Stanley, a research professor and senior policy analyst, respectively, at the </span><a href="https://regulatorystudies.columbian.gwu.edu/"><span style="font-weight: 400;">GW Regulatory Studies Center</span></a><span style="font-weight: 400;">, who wrote the Pew-funded report, found that the DEA and SAMHSA have not one, but</span><i><span style="font-weight: 400;"> several</span></i><span style="font-weight: 400;"> different ways in which they can extend current telehealth policies. And while both authors told </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;"> that their work focused on what </span><i><span style="font-weight: 400;">could </span></i><span style="font-weight: 400;">be done rather than on whether it </span><i><span style="font-weight: 400;">should </span></i><span style="font-weight: 400;">be done, their findings play an essential role in furthering the public conversation.</span></p>
<p><span style="font-weight: 400;">According to Dooling and Stanley’s findings, both agencies could extend telemedicine flexibilities </span><span style="font-weight: 400;">permanently and</span> <span style="font-weight: 400;">unilaterally under a statutory exemption in </span><a href="https://www.deadiversion.usdoj.gov/fed_regs/rules/2020/fr0930_2.htm"><span style="font-weight: 400;">the Ryan Haight Act</span></a><span style="font-weight: 400;">, which, the authors note, gives the agencies broad discretion to allow practitioners to prescribe controlled substances without an in-person examination. However, such regulations only apply to X-waivered physicians—meaning SAMHSA would need to issue a companion policy to opioid treatment providers, exempting them from in-person examination requirements.</span></p>
<p><span style="font-weight: 400;">Next, the authors found that the Ryan Haight Act gives the DEA the authority to set up special registration programs for telemedicine. Another piece of legislation, </span><a href="https://www.congress.gov/bill/115th-congress/house-bill/6"><span style="font-weight: 400;">the SUPPORT for Patients and Communities Act of 2018</span></a><span style="font-weight: 400;">, actually directed the DEA to do so by 2019, but the agency has yet to follow through. Dooling and Stanley note that, as with the previous option, SAMHSA would also need to issue that same companion policy.</span></p>
<p><span style="font-weight: 400;">Finally, the report found that both agencies could use declared opioid public health emergencies to extend current telehealth policies although this wouldn’t make them permanent.</span></p>
<p><span style="font-weight: 400;">“The public health emergency declaration for the opioid epidemic is already on the books,” Dooling said. “We have declared that it&#8217;s a public health emergency. And so the question is, what flows from that?”</span></p>
<p><span style="font-weight: 400;">Dooling and Stanley’s matter-of-fact assessment shows what the DEA and SAMHSA </span><i><span style="font-weight: 400;">can</span></i><span style="font-weight: 400;"> do. Whether the agencies will take any of these steps is highly doubtful, however, given their well documented inherent biases—illustrated by the fact that they didn’t allow telemedicine until a pandemic practically forced them into it.</span></p>
<p><span style="font-weight: 400;">But publicizing the agencies’ powers in this area </span><i><span style="font-weight: 400;">might</span></i><span style="font-weight: 400;"> just make this a productive avenue for public pressure.</span></p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Telemedicine Must Have a Future</h4>
<p><span style="font-weight: 400;">Activists in the harm reduction community have long lobbied the federal government for telemedicine options to </span><a href="/coronavirus-telehealth-overdose/"><span style="font-weight: 400;">help those in rural communities</span></a><span style="font-weight: 400;"> and others without access to treatment providers. As the GWU report noted, places like Wyoming County, West Virginia, which had the state’s highest overdose death rate from 2014 to 2016, were also without a single physician <a href="/buprenorphine-x-waiver-biden/">X-waivered</a> to prescribe buprenorphine.</span></p>
<p><span style="font-weight: 400;">As promising as the temporary telemedicine regulations are, individual physicians still have leeway to practice within their preconceived biases. Last summer, when my buprenorphine doctor asked me about the burden of going for urine screens, I knew he wasn’t really asking about me. After all, according to my chart, which was right in front of him, I went every month. The question was a compare-and-contrast with his broader patient population.</span></p>
<p><span style="font-weight: 400;">“A few other patients say it’s difficult to go for a urine,” he said. “I wanted to see if that’s true.”</span></p>
<p><span style="font-weight: 400;">As a middle-class white man who works from home and has the freedom to come and go, I’m not the best barometer. Plenty of research shows that </span><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2764663"><span style="font-weight: 400;">low-income people of color</span></a><span style="font-weight: 400;">, along with single mothers and other vulnerable populations, have difficulty accessing health care of any kind, pandemic or not.</span></p>
<p><span style="font-weight: 400;">Had I said yes, I could have spoken with my doctor about how marginalized people face so many more barriers than I do in getting monthly urines. But I worried it might lose me my script.</span></p>
<p><span style="font-weight: 400;">“No,” I said, like a coward. “Going for a urine screen isn’t difficult at all.”</span></p>
<p><span style="font-weight: 400;">For buprenorphine providers in the harm reduction community, such as Philadelphia’s Shoshi Aronowitz, the adoption of telemedicine for patients who would otherwise be left untreated is a net positive. Aronowitz is a research fellow in the </span><a href="https://nationalcsp.org/"><span style="font-weight: 400;">National Clinician Scholars Program</span></a><span style="font-weight: 400;"> at the University of Pennsylvania. She also works as a family nurse practitioner at some of the city’s more well-established harm reduction-based substance use treatment centers.</span></p>
<p><span style="font-weight: 400;">“Telehealth is great because you don&#8217;t have to worry about how close the clinician lives to you,” said Aronowitz. She noted the model benefits both rural residents and Black and Hispanic communities—communities that are less likely to have access to buprenorphine providers than white neighborhoods.</span></p>
<p><span style="font-weight: 400;">“Then there&#8217;s lots of people also who live in areas where there are a lot of clinicians, or at least some clinicians,” Aronowitz continued, explaining that a host of reasons beyond geography</span> can<span style="font-weight: 400;"> make telehealth necessary. “But maybe because of a disability, for example, they&#8217;re unable to travel to a clinic, or because of stigma they don&#8217;t want to travel to a clinic, or even because of their job or their family responsibilities having to show up at a clinic frequently—because you do for OUD treatment—is not going to work.”</span></p>
<blockquote><p>She added that she “can’t even begin to think about” the number of patients who<span style="font-weight: 400;"> are now in her care </span><i><span style="font-weight: 400;">because</span></i><span style="font-weight: 400;"> of telemedicine policies.</span></p></blockquote>
<p><span style="font-weight: 400;">Telemedicine isn’t an answer in and of itself, as can be seen in </span><a href="https://www.statnews.com/2021/02/16/as-pandemic-ushered-in-isolation-financial-hardship-overdose-deaths-reached-new-heights/"><span style="font-weight: 400;">the rise in overdose deaths during the pandemic</span></a><span style="font-weight: 400;">. In addition to low-barrier treatments that </span><a href="https://academic.oup.com/jamia/article/28/2/389/5988542"><span style="font-weight: 400;">bridge the digital divide</span></a><span style="font-weight: 400;">, telehealth policies need to embrace holistic avenues that aren’t awash in stigma.</span></p>
<p><span style="font-weight: 400;">Aronowitz understands de-platforming stigma better than most. Earlier this year, she published </span><a href="https://pubmed.ncbi.nlm.nih.gov/33358617/"><span style="font-weight: 400;">an article suggesting that urine screens</span></a><span style="font-weight: 400;"> should</span> <span style="font-weight: 400;">no longer be central to substance use care. For those doctors who still lean on UDS, </span><span style="font-weight: 400;">or even patients who choose to use it as a measure of their own success,</span><span style="font-weight: 400;"> Aronowitz told </span><i><span style="font-weight: 400;">Filter</span></i><span style="font-weight: 400;"> that there are less traumatizing ways to go about it that don’t include going out to a lab in the middle of a pandemic. Urine cups and oral swabs can be sent through the mail, she said, with the latter observable by the doctor over Zoom.</span></p>
<p><span style="font-weight: 400;">And when it comes to induction via telemedicine, Aronowitz believes close contact is crucial. She said that providers should build up from smaller doses, ask lots of questions, and check-in often to see if the patient has any concerns.</span></p>
<p><span style="font-weight: 400;">“It would be horrible if [telehealth policies] were rolled back,” said Aronowitz.</span> She added that she “can’t even begin to think about” the number of patients who<span style="font-weight: 400;"> are now in her care </span><i><span style="font-weight: 400;">because</span></i><span style="font-weight: 400;"> of the policies instituted at the pandemic&#8217;s start.</span></p>
<p><span style="font-weight: 400;">“They weren&#8217;t able to come in before,” she said. “So they can&#8217;t come in now.”</span></p>
<p><span style="font-weight: 400;">My buprenorphine doctor might never read this piece—in fact, I doubt he will. If he does, perhaps we could finally have that conversation about marginalized people and the need for a buprenorphine approach that truly embraces harm reduction.</span></p>
<p><span style="font-weight: 400;">Or he may just revoke my script.</span></p>
<hr />
<p>&nbsp;</p>
<p><em>Photo by <a href="https://unsplash.com/@designmesk?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Marek Levák</a> on <a href="/collections/5048129/telehealth?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Unsplash</a> </em></p>
<p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=%2Ftelehealth-buprenorphine-samhsa-dea%2F&linkname=Extending%20Telehealth%20Bupe%20Past%20the%20Pandemic%20Wouldn%E2%80%99t%20Require%20Congress" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=%2Ftelehealth-buprenorphine-samhsa-dea%2F&linkname=Extending%20Telehealth%20Bupe%20Past%20the%20Pandemic%20Wouldn%E2%80%99t%20Require%20Congress" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_email" href="https://www.addtoany.com/add_to/email?linkurl=%2Ftelehealth-buprenorphine-samhsa-dea%2F&linkname=Extending%20Telehealth%20Bupe%20Past%20the%20Pandemic%20Wouldn%E2%80%99t%20Require%20Congress" title="Email" rel="nofollow noopener" target="_blank"></a></p><p>The post <a href="/telehealth-buprenorphine-samhsa-dea/">Extending Telehealth Bupe Past the Pandemic Wouldn’t Require Congress</a> appeared first on <a href="/">Filter</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>When My Suboxone Doctor Quit on Me, It Left a Frightening Void</title>
		<link>/suboxone-doctor-quit/</link>
		
		<dc:creator><![CDATA[Brandon A. Dorfman]]></dc:creator>
		<pubDate>Tue, 02 Feb 2021 14:34:32 +0000</pubDate>
				<category><![CDATA[FilterMag]]></category>
		<category><![CDATA[Use + Harm Reduction]]></category>
		<category><![CDATA[addiction]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[MAT]]></category>
		<guid isPermaLink="false">/?p=11430</guid>

					<description><![CDATA[<p>Early in 2020, shortly before pandemic entered the everyday lexicon and face masks became de rigueur, I went to my ...</p>
<p>The post <a href="/suboxone-doctor-quit/">When My Suboxone Doctor Quit on Me, It Left a Frightening Void</a> appeared first on <a href="/">Filter</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span class="wpsdc-drop-cap">E</span>arly in 2020, shortly before <i>pandemic </i>entered the everyday lexicon and face masks became <i>de rigueur</i>, I went to my scheduled Suboxone appointment to find the doctor’s office more sterile than usual.</p>
<p>The waiting room walls, once cluttered with rock festival posters, pharmaceutical displays and photocopied <i>warnings</i>—the doctor <i>does not </i>prescribe opioid medications, the doctor <i>does not</i> make up missed Suboxone appointments, the doctor <i>does not </i>replace lost Suboxone prescriptions—were now bare. Packed boxes stood piled in the front of the suite, where the familiar cadre of nurses and office managers had been replaced by a skeleton crew of one.</p>
<blockquote><p>On my way to the car, I saw him tossing boxes in the dumpster.</p></blockquote>
<p>My first thoughts leaned toward office renovations. Maybe they’re painting the walls, I naively said to myself. But the sullen look on the face of the remaining office manager—a kind woman with whom I’d shared small talk about my kids and the weather over the years—told me I was wrong. The doctor was immediately retiring, she told me, and this would be my last appointment. There would be no questions about the progress of my recovery, no checking my blood pressure, and no urine samples.</p>
<p>Within minutes, the doctor had handed me a list of SAMHSA-approved providers in the Philadelphia region, a copy of my patient file, and a 30-day Suboxone script. On my way to the car, I saw him tossing boxes in the dumpster.</p>
<p>I took the news to my therapist at the <a href="https://dbhids.org/">Department of Behavioral Health Services</a> (DBHIDS) satellite office in Northeast Philadelphia. She then spoke to the department’s Suboxone nurse on my behalf, before informing me that I would be required to participate in an intensive outpatient program in order to continue my care.</p>
<p>“Our Suboxone program requires group therapy,” she told me, informing me of one of the many barriers I’d face on my way to continuing treatment—the apparent need to sit in a room filled with strangers three hours a day, three days a week, and talk about my feelings. I slumped into her office sofa—it was one of my last in-person appointments before the pandemic hit—offering fruitless protestations.</p>
<p>After three years in recovery—spent continuously adhering to a strict schedule of <a href="/suboxone-street-philadelphia/">Suboxone</a> (the brand name for a buprenorphine/naloxone formulation), <a href="https://www.webmd.com/drugs/2/drug-35/zoloft-oral/details">Zoloft</a>, individual therapy and clean urines—all I needed was a new doctor to write me a script for buprenorphine.</p>
<p>What I would find instead were barriers to treatment, including a list of <a href="https://www.samhsa.gov/medication-assisted-treatment/practitioner-program-data/treatment-practitioner-locator">SAMHSA-approved Suboxone providers</a> <i>not </i>offering the medication in practice and <a href="/buprenorphine-x-waiver-costs-lives/">X-Waivered doctors</a> not accepting new patients. I also experienced burdensome requirements to join group therapy programs through Philly’s DBHIDS—part of an ironic, near-Kafkaesque nightmare, seeing as I had <i>left</i> the department’s intensive outpatient program three years earlier, determined to take control of my own recovery after they refused to give me Suboxone.</p>
<p>&nbsp;</p>
<h4 style="text-align: center;">The Depressing Norm of Stigma</h4>
<p>Though born of sudden bad luck, my situation reflected a perfectly ordinary reality: that access to medications for opioid use disorder (MOUD) in the US is plagued by stigma against people who use drugs. Several <a href="https://pubmed.ncbi.nlm.nih.gov/31913966/">studies</a> mirror my personal experience and show that it was far from unique.</p>
<p>Among those studies is a <a href="https://www.acpjournals.org/doi/10.7326/m18-3457">recent one</a> led by <a href="https://www.hsph.harvard.edu/">Harvard School of Public Health</a> Assistant Professor <a href="https://www.hsph.harvard.edu/michael-barnett/">Michael Barnett</a>, which sought to assess real-world access to buprenorphine treatment. The investigation, colloquially referred to as a “secret shopper study,” found that many providers neither offered new appointments nor provided first-appointment induction to people who were currently using unprescribed opioids. For Medicaid patients like myself, the outcomes were worse.</p>
<p>“If someone with opioid use disorder is coming into the clinic and ready to start buprenorphine, that&#8217;s when they should receive it,” said Dr. Barnett, adding that, on a positive note, the study found patient wait times were short once they could make an appointment. “Every single week, every single day that you wait and you don&#8217;t actually take advantage of that opportunity is basically just saying we’re ok with overdoses and people dying.”</p>
<blockquote><p>“Doctors can&#8217;t just leave and say, ‘Here&#8217;s a list of numbers.&#8217; It has to be more than that.&#8221;</p></blockquote>
<p>Although my doctor gave me 30 pills on his way out the door, it took me six weeks to find a new provider—a frustrating, discouraging process made manageable only because I, like many of my peers, have learned to stash away extra medication over the years. Every doctor’s warning, every pharmacist’s glare, and every paperwork kerfuffle with my health insurance made me realize that the system might at any moment take away my medication when I need it most.</p>
<p>My search began with the names of local providers cross-listed with those of Medicaid doctors. I’d spent my first year in treatment paying out-of-pocket, something I neither wanted nor could afford to do again. One local recovery center that touted its statistics and “one day at a time” memes on social media chose not to return my calls. Several Medicaid-approved physicians were no longer accepting Medicaid.</p>
<p>Only one doctor would see new patients. “The doctor can see you in two months,” a woman told me, matter-of-factly, on the phone. Neither my script nor my stash would last me that long.</p>
<p>I don’t know how many providers I called, how many tuned me down, how many weren’t X-Waivered, or how many weren’t taking new patients. I don’t know how many barriers I encountered, but it was enough—enough that I’m glad I stashed away pills. Without them, what would my options have been, and how much risk would they have entailed? Even <i>with</i> them, I was working on borrowed time.</p>
<p>“[Doctors] can&#8217;t just leave and say, ‘Here&#8217;s a list of numbers.&#8217; It has to be more than that,” said Dr. Barnett, who, as luck would have it, also <a href="https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2773066">studied the general problem of continuation of care</a>. “Patients need a transition plan.”</p>
<p>According to his research, which focused on primary care physicians, the loss of a doctor without a proper transition plan resulted in an increase in the use of specialty, emergency room, and urgent care services, all of which resulted in adverse health outcomes for the populations studied.</p>
<p>As Dr. Barnett noted earlier, barriers such as discontinuation of care and difficulty finding treatment have exaggerated consequences for MOUD patients, too often resulting in overdose and death. The problem continues to play out in <a href="https://www.pbs.org/newshour/health/whats-behind-the-historic-spike-in-drug-overdose-deaths-under-covid-19">real-time and record numbers during the COVID-19 pandemic</a> as quarantines and stay-at-home orders prevent people from accessing the lifesaving treatment they need.</p>
<p>Neither are such risks evenly distributed among different demographics of MOUD patients. As a lower-middle class, white Medicaid patient in a large urban area, finding access was already extremely hard. But our <a href="/to-address-addiction-confront-racism-in-our-health-and-justice-systems/">racist and classist medical structure</a> means that many other people, including people of color and those living in rural areas and/or experiencing poverty, can have it much worse.</p>
<blockquote><p>“Countless people do avoid getting help.&#8221;</p></blockquote>
<p>According to Daniel Garrett, who lives in a small town in Tennessee, lack of access to buprenorphine and other MOUD options is a feature of the system. “Countless people do avoid getting help because they can&#8217;t find Suboxone providers,” Garrett, who runs the website <a href="http://tennesseeharmreduction.com/">Tennessee Harm Reduction</a>, told <i>Filter</i>. “I&#8217;ve heard many fellow opioid users say they don&#8217;t know where to find Suboxone doctors at.”</p>
<p>Stigma against MOUD can be especially acute in his part of rural Tennessee, said Garrett. He related how last summer, his own search for Suboxone saw him facing unnecessary stints in detox, roundabout trips to various pharmacies, and weekly visits to cash-hungry doctors—a major financial burden for someone without health insurance.</p>
<p>Although, in the end, Garrett found treatment through a grant-funded program with the help of his connections to Tennessee’s harm reduction community, the state’s issues remain. It’s tellingly rare for MOUD providers to advertise their services in rural areas; Garrett can only recall two in Northwest Tennessee in recent years: a short-lived digital billboard, and some blue-and-white ads slapped on telephone poles. And despite spending a good deal of his time handing out syringes, naloxone and other items in the drug-user community, “I heard nothing about these ads,” from anyone in that community, he said.</p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Nixing the X-Waiver Would Be Just a Start</h4>
<p>In recent weeks, the structural problems at the base of many of these barriers, most notably the X-Waiver, are back in the public sphere. The Trump administration, somewhere between burning down the Capitol and being impeached for a record-breaking second time, moved to nix the now-infamous policy, giving doctors more flexibility to treat patients with and prescribe Buprenorphine. But after his first week in office, <a href="/biden-administration-buprenorphine-deregulation/">President Biden blocked that decision</a>. (Pennsylvania legislators, meanwhile, <a href="/pennsylvania-bill-buprenorphine-access/">will consider a bill</a> that would make it harder to obtain X-Waivers in the state.)</p>
<p>Whether or not the Biden administration holds to that course, Dr. Barnett pointed out that many barriers to treatment are<i> provider</i>-erected—above and beyond the X-Waiver regulation, and because of stigma against people who use drugs.</p>
<p>“The X-Waiver is gone right now,” said Dr. Barnett, speaking before the Biden administration’s position had emerged. “But the culture and patterns of prescribing and comfort level of prescribing that the X-Waiver put into place did not disappear.”</p>
<p>“It&#8217;s much better to have no X-Waiver than to have an X-Waiver,” he continued. “But a lot of the damage has been done and without additional effort, I don&#8217;t know that it&#8217;s going to necessarily evaporate all barriers.”</p>
<blockquote><p>I stash away a couple of extra pills, just in case.</p></blockquote>
<p>My new Suboxone doctor’s office is about 15 minutes away from my house, just a short distance from <a href="/northeast-philly-redlining-methadone/">a methadone clinic</a> that once sent the neighborhood into a fury. He calls my script into the pharmacy every month—something my old doctor told me wasn’t possible as he handed me a paper prescription with each visit. When COVID hit, he switched to a <a href="/coronavirus-telehealth-overdose/">telehealth model</a>, protecting the safety of patients in his care.</p>
<p>And every month, he asks me about the progress of my recovery, whether I have any cravings, and if I want to keep the same dose. With that last question, I always say “yes,” so I can stash away a couple of extra pills, just in case he decides to retire.</p>
<p>&nbsp;</p>
<hr />
<p><em>Photo by <a href="https://unsplash.com/@jsalvino?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">John Salvino</a> on <a href="https://unsplash.com/s/photos/padlock?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Unsplash</a></em></p>
<p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=%2Fsuboxone-doctor-quit%2F&linkname=When%20My%20Suboxone%20Doctor%20Quit%20on%20Me%2C%20It%20Left%20a%20Frightening%20Void" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=%2Fsuboxone-doctor-quit%2F&linkname=When%20My%20Suboxone%20Doctor%20Quit%20on%20Me%2C%20It%20Left%20a%20Frightening%20Void" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_email" href="https://www.addtoany.com/add_to/email?linkurl=%2Fsuboxone-doctor-quit%2F&linkname=When%20My%20Suboxone%20Doctor%20Quit%20on%20Me%2C%20It%20Left%20a%20Frightening%20Void" title="Email" rel="nofollow noopener" target="_blank"></a></p><p>The post <a href="/suboxone-doctor-quit/">When My Suboxone Doctor Quit on Me, It Left a Frightening Void</a> appeared first on <a href="/">Filter</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Biden Has a COVID Plan, But Won’t Learn Deeper Health Care Lessons</title>
		<link>/biden-covid-healthcare/</link>
		
		<dc:creator><![CDATA[Helen Redmond]]></dc:creator>
		<pubDate>Thu, 21 Jan 2021 14:02:03 +0000</pubDate>
				<category><![CDATA[FilterMag]]></category>
		<category><![CDATA[Politics + Legalization]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[social equity]]></category>
		<guid isPermaLink="false">/?p=11344</guid>

					<description><![CDATA[<p>Donald Trump, the corrupt, narcissistic demagogue, has left the Whitehouse in the midst of a pandemic that killed 400,000 people ...</p>
<p>The post <a href="/biden-covid-healthcare/">Biden Has a COVID Plan, But Won’t Learn Deeper Health Care Lessons</a> appeared first on <a href="/">Filter</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span class="wpsdc-drop-cap">D</span>onald Trump, the corrupt, narcissistic demagogue, has left the Whitehouse in the midst of a pandemic that killed<a href="https://covid.cdc.gov/covid-data-tracker/#cases_casesper100klast7days"> 400,000 people</a> on his watch, with no end yet in sight. His successor, Joe Biden, has a COVID plan. But nothing about him suggests that he will learn the deeper lessons of this preventable catastrophe.</p>
<p>From the start, Trump dismissed the threat of COVID-19. His administration wouldn’t implement a unified, national strategy, instead leaving 50 state governors to figure out a response. Trump refused to marshal the vast  resources of the<a href="https://www.vox.com/2020/4/4/21208122/ppe-distribution-trump-administration-states"> federal government</a> to coordinate the production or distribution of personal protective equipment to hospitals overwhelmed by coronavirus, putting staff at great risk. He defiantly refused to wear a face mask and mocked those who did. In September, he held a<a href="https://www.statnews.com/2020/10/19/seeing-rose-garden-superspreader-convocation-as-a-never-event/"> superspreader event</a> in the Rose Garden that<a href="https://www.npr.org/sections/latest-updates-trump-covid-19-results/2020/10/03/919851907/at-least-7-people-test-positive-for-coronavirus-after-rose-garden-event-for-barr"> infected his staff and family</a>. Trump himself was infected and<a href="https://www.nytimes.com/live/2020/10/05/world/covid-trump"> downplayed</a> its severity. At every turn, the former president rejected evidence and science, obstructing the nation’s ability to control the spread of the coronavirus.</p>
<p>Donald Trump’s actions and inactions are directly responsible for not preventing the sickening and death of millions of Americans. He has blood on his hands and must be held accountable.</p>
<p>The Biden administration has inherited a Trumpian dystopia: A new wave is crashing over the country, the<a href="https://nymag.com/intelligencer/article/americas-vaccine-rollout-disaster.html"> vaccine rollout is a disaster</a> and a skeptical and scared public doesn’t believe the federal government can do anything right.</p>
<p>To take on the pandemic, Biden announced a<a href="https://www.cnn.com/2020/12/08/politics/biden-100-million-vaccines-100-days/index.html"> three-point plan</a> that includes the distribution of 100 million vaccine shots in his first 100 days in office—enough to cover 50 million people—a face mask mandate and efforts to reopen schools safely. Moreover, Biden said he’ll use the<a href="https://abcnews.go.com/Politics/president-elect-biden-set-federal-covid-19-vaccine/story?id=75086591"> Defense Production Act</a> to ramp up production of materials necessary to roll out the vaccine.</p>
<p>&#8220;My first 100 days won&#8217;t end the COVID-19 virus. I can&#8217;t promise that,” Biden <a href="https://www.bbc.com/news/world-us-canada-55238092">said</a>. “But we did not get into this mess quickly. We&#8217;re not going to get out of it quickly.”</p>
<blockquote><p>The pandemic has brutally exposed how our dysfunctional, for-profit insurance system cannot adequately respond to a public health crisis on this scale.</p></blockquote>
<p>The Biden administration actually believes in following the science around the coronavirus and the highly respected Dr. Anthony Fauci will be his chief medical advisor, meeting with the COVID-19 pandemic response team.</p>
<p>Yet scientific literacy and mass vaccination, while necessary, are not sufficient. Because with each passing month, the COVID-19 pandemic has brutally exposed how our dysfunctional, for-profit insurance system cannot adequately respond to a public health crisis on this scale.</p>
<p>Economically, the pandemic caused a massive recession and historic levels of job loss. But health coverage in the United States is tied to employment status. It’s estimated that over<a href="https://www.kff.org/coronavirus-covid-19/issue-brief/eligibility-for-aca-health-coverage-following-job-loss/"> 26 million people</a> have lost employer-sponsored coverage during the pandemic. It’s clear now, if it wasn’t before, how illogical it is to link insurance to employment. And it’s dangerous. The uninsured often delay testing and treatment, fearing the cost, and that is deadly in the era of COVID-19—as it always has been with other health crises.</p>
<p>“How is this going to play out in the next year and how will we control the pandemic if people fear getting charged for a test?”<a href="https://www.bmj.com/content/370/bmj.m3097"> asked</a> Sara Collins<a href="https://www.bmj.com/content/370/bmj.m3097">,</a> vice president for health care coverage and access at the Commonwealth Fund. People without insurance and<a href="https://www.bmj.com/content/370/bmj.m3097"> even those who do</a> have coverage face staggering medical bills if they are sickened by the coronavirus, which have left the gravely ill on ventilators in intensive care units for weeks, even months. The charges can run anywhere from hundreds to tens of thousands of dollars. Americans are receiving<a href="https://www.nytimes.com/2020/08/03/upshot/nj-coronavirus-medical-bill.html?action=click&module=RelatedLinks&pgtype=Article"> “surprise bills”</a> for outrageous amounts for care connected with COVID-19. Collection agencies and<a href="https://pnhp.org/news/another-gift-of-covid-19-medical-bankruptcy/"> medical bankruptcy</a> await thousands of coronavirus survivors.</p>
<p>Our profit-driven, multi-payer model of insurance is expensive, complex, offers limited coverage and leaves millions uninsured. It has always failed—above all for the marginalized populations devastated by previous and ongoing health crises like HIV/AIDS and overdose. But it has failed spectacularly and <i>visibly</i>, in a way that has dominated national attention like never before, in the face of the mutating coronavirus.</p>
<p>Shamefully, the United States is alone among rich-world countries in not providing healthcare to its entire population. Countries in Europe and Asia—like<a href="https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(20)30044-4/fulltext"> Taiwan</a>, for example—that have universal coverage and extensive public health infrastructure were able to coordinate rapid, national responses. Even the UK, where the government is guilty of many pandemic failures, has rolled out vaccinations <a href="https://www.ft.com/content/cdfb7b28-8306-4db2-8dd6-4f85a92b1778">far more efficiently</a> than the US thanks to its centralized, taxpayer-funded National Health Service.</p>
<p>What is desperately needed in the US is Medicare for All. Rep. Pramila Jayapal (D-Wash.) is the sponsor of<a href="https://www.congress.gov/bill/116th-congress/house-bill/1384/text"> legislation</a> that would abolish the private insurance industry, creating a single-payer, national health insurance system that guarantees universal care. No cost-sharing, no deductibles, no coinsurance or copayments. It’s popular, too: <a href="https://thehill.com/hilltv/what-americas-thinking/412545-70-percent-of-americans-support-medicare-for-all-health-care">70 percent</a> of people polled support Medicare for All, as do 120 House members–a majority of Democrats. Even Warren Buffett, Al Gore and Jimmy Carter are on board for single-payer. But there is one very powerful Democrat who is not: President Joseph R. Biden Jr.</p>
<p>In a video on Biden’s<a href="https://joebiden.com/healthcare/"> website</a> he explains, “In the Democratic debate in Miami, the question was asked if we support eliminating private health insurance. Some said yes, I said absolutely not. I believe we have to protect and build on Obamacare … I’m not for getting rid of Obamacare.”</p>
<p>&nbsp;</p>
<h4 style="text-align: center;">Expanding ACA Falls Far Short</h4>
<p>The Affordable Care Act (ACA, commonly called Obamacare) was passed in 2010. Biden has a personal stake in retaining the ACA because he played a major role in its fraught passage. During the signing ceremony, a microphone <a href="https://www.theguardian.com/world/richard-adams-blog/2010/mar/23/joe-biden-obama-big-fucking-deal-overheard">recorded him</a> whispering loudly in Obama’s ear, “This is a big fucking deal!”</p>
<p>The two most important aspects of the ACA were the expansion of Medicaid—although<a href="https://www.kff.org/medicaid/issue-brief/status-of-state-medicaid-expansion-decisions-interactive-map/"> 12 states refused</a>—and the fact that health insurance companies can no longer deny coverage or charge more because of a<a href="https://www.hhs.gov/healthcare/about-the-aca/pre-existing-conditions/index.html"> “pre-existing condition.”</a></p>
<blockquote><p>How can you defend a health care reform that is unaffordable and abandons millions of people?</p></blockquote>
<p>But almost 11 years in, it’s clear that Obamacare has failed. In 2019, 73 percent of uninsured adults said that they were uninsured because the<a href="https://www.kff.org/uninsured/issue-brief/key-facts-about-the-uninsured-population/"> cost of coverage</a> was too expensive. Another widespread problem is health insurer claim denial. Nearly<a href="https://www.kff.org/private-insurance/issue-brief/claims-denials-and-appeals-in-aca-marketplace-plans/"> one in five claims</a> for in-network care by patients with ACA plans are denied and some insurers reject about 40 percent of claims. To be sure, the ACA lowered the number of uninsured, but<a href="https://www.kff.org/uninsured/issue-brief/key-facts-about-the-uninsured-population/"> 28.9 million</a> still have no access to care. How can you defend a health care reform that is unaffordable and abandons millions of people? Especially during an unprecedented pandemic!</p>
<p>The new president’s approach to the healthcare crisis amounts to more piecemeal reforms that won’t contain costs and won’t cover everyone. Biden wants to shore up the ACA by increasing subsidies for people to buy private health coverage on the state marketplace exchanges. That funnels yet more public money into the coffers of private insurance companies at a moment when these corporations’ profits are skyrocketing. Pandemic profiteers UnitedHealth reported<a href="https://www.nytimes.com/2020/08/05/health/covid-insurance-profits.html"> net earnings</a> of $6.7 billion in the second quarter of 2020, compared to $3.4 billion for the same period in 2019. Anthem’s net income for those periods increased from $1.1 billion to $2.3 billion.</p>
<p>Biden, too, is on the take. By mid-2019, he had accepted almost $100,000 from the<a href="https://www.opensecrets.org/news/2019/07/20dems-are-taking-money-healthcare/"> insurance and pharmaceutical</a> industries to fund his 2020 presidential run—more than any other Democratic candidate. One of his <a href="https://theintercept.com/2019/12/31/joe-biden-fundraiser-centene-for-profit-prison/">top fundraisers</a> is Michael F. Neidorff, the CEO of Centene—a health insurance corporation that is heavily invested in the prison healthcare market.</p>
<p>On the campaign trail, Biden announced that he would create a government-run health plan, similar to Medicare, called the “public option.” People would have to pay for insurance under this plan, as an alternative to buying it from private companies. Insurance companies<a href="https://www.npr.org/sections/health-shots/2020/11/11/933522346/biden-wants-to-lower-medicare-eligibility-age-to-60-but-hospitals-push-back"> successfully rallied opposition to this option</a> when it was introduced during the health care reform debates in 2009, and they will try again. Biden also wants to lower the<a href="https://www.npr.org/sections/health-shots/2020/11/11/933522346/biden-wants-to-lower-medicare-eligibility-age-to-60-but-hospitals-push-back"> eligibility age</a> for Medicare from 65 to 60.</p>
<blockquote><p>The system needs to be completely rebuilt on the principles of patients not profits, and healthcare as a human right.</p></blockquote>
<p>Both of these reforms are an attempt to shut down the movement for Medicare for All. Even if enacted, they represent small fixes to an inhumane healthcare system—a system that needs to be completely rebuilt on the principles of patients not profits and healthcare as a human right, not a commodity. Medicare for All embodies those vital principles. Biden’s proposals to build on Obamacare do not.</p>
<p>During a presidential debate about health care last March, Biden<a href="https://jacobinmag.com/2020/03/joe-biden-italy-coronavirus-public-health-care-debate"> said,</a> “With all due respect for Medicare for All, you have a single-payer system in Italy—it doesn’t work there.”</p>
<p>This was in response to Senator Bernie Sanders’<a href="https://thehill.com/policy/healthcare/487719-biden-sanders-debate-medicare-for-all-as-response-to-coronavirus"> comment</a>: &#8220;One of the reasons we are unprepared [for the pandemic] is we don’t have a system. We’ve got thousands of private insurance plans. That is not a system.” Sanders added that the coronavirus exposes the &#8220;incredible weakness&#8221; of  US healthcare, in part because millions of Americans are uninsured or underinsured.</p>
<p>So with all due respect to President Biden, no one in Italy is <i>ever</i> uninsured. The concept does not exist. No Italian will ever get a surprise medical bill for $500,000, be forced into medical bankruptcy, not fill a prescription because it costs too much money, or ask right before being placed on a ventilator in order to breathe,<a href="/exit-bernie-healthcare-disaster/"> “Who’s going to pay for it?”</a></p>
<p>&nbsp;</p>
<hr />
<p>&nbsp;</p>
<p><em>Photograph of COVID-19 vaccinations in New York City by Helen Redmond</em></p>
<p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=%2Fbiden-covid-healthcare%2F&linkname=Biden%20Has%20a%20COVID%20Plan%2C%20But%20Won%E2%80%99t%20Learn%20Deeper%20Health%20Care%20Lessons" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=%2Fbiden-covid-healthcare%2F&linkname=Biden%20Has%20a%20COVID%20Plan%2C%20But%20Won%E2%80%99t%20Learn%20Deeper%20Health%20Care%20Lessons" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_email" href="https://www.addtoany.com/add_to/email?linkurl=%2Fbiden-covid-healthcare%2F&linkname=Biden%20Has%20a%20COVID%20Plan%2C%20But%20Won%E2%80%99t%20Learn%20Deeper%20Health%20Care%20Lessons" title="Email" rel="nofollow noopener" target="_blank"></a></p><p>The post <a href="/biden-covid-healthcare/">Biden Has a COVID Plan, But Won’t Learn Deeper Health Care Lessons</a> appeared first on <a href="/">Filter</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
